GROWTH PROMOTING PEPTIDES, AND USES THEREOF

Abstract

A natural peptide comprising a cellular growth promoting fragment of a protein selected from SEQ ID NO’s: 1 to 13, and a composition comprising a plurality of growth promoting peptides, is described. Also disclosed is the use of the peptides and compositions in prevention of ageing of human skin, treatment of diseases or conditions characterised by damaged epithelial cells or tissue such as colon cancer and peripheral inflammatory disorders, and wound treatment. Specific pea and rice protein derived peptides are described in SEQ ID NO’s: 15 to 505, and 546 to 704.

Claims

1. A peptide of 5 to 50 amino acids in length and comprising a sequence selected from SEQUENCE ID NO: 15-282, 286-471, 473-505, 546-704 and 717-775.

Description

BRIEF DESCRIPTION OF THE FIGURES

[0286] FIGS. 1 to 100: Effect of synthetic peptides of the invention on proliferation of Human Dermal Fibroblasts (HDF).

[0287] FIG. 101: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0288] FIG. 102: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0289] FIG. 103: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0290] FIG. 104: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0291] FIG. 105: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0292] FIG. 106: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0293] FIG. 107: Effect of synthetic peptide of the invention (SEQ ID NO: 284) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0294] FIG. 108: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0295] FIG. 109: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0296] FIG. 110. shows the integrity controls and viability controls for the assay system.

[0297] FIG. 111. % of elastin expression in superficial dermis compared to control (water or DMSO) for peptides P1, P2 and P3 * shows significant increases of elastin expression in superficial AND middle dermis.

[0298] FIG. 112. % of elastin expression in middle dermis compared to control (water or DMSO) for peptides P1, P2 and P3. * shows significant increases of elastin expression in superficial AND middle dermis.

[0299] FIG. 113. % of cell proliferation in the basal layer of epidermis compared to control (water or DMSO) for peptides P6 and P8, and peptide compositions P9 and P10 * shows significant increases.

[0300] FIGS. 114. Histological analysis of the elastic fibers (+catechin, x200)

[0301] FIGS. 115. Immunohistochemical evaluation of the mitotic index (Ki67, x400)

DETAILED DESCRIPTION OF THE INVENTION

Example 1 - Cell Proliferation Assay

[0302] BrDu is incorporated into newly synthesised DNA strands of actively proliferating cells. Following partial denaturation of double stranded DNA, Brdu is detected immunochemically allowing the assessment of the population of cells which are synthesizing DNA.

[0303] Human Dermal Fibroblasts (HDF - Sigma 10605a) were seeded in a 96 well plate at 10,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

[0304] Following the initial 24 h incubation the cells were incubated with 5 .Math.g/ml, 0.5 .Math.g/ml or 0.05 .Math.g/ml synthetic peptide for 24 h respectively.

[0305] After 18 h incubation with synthetic peptides 20 .Math.l BrDu reagent was added to each well.

[0306] At 24 h incubation the cell were fixed and the amount of 2-DG6P was measured using the BrdU Cell Proliferation Assay, all steps were carried out according to the manufacturer’s instructions.

[0307] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates greatER incorporation of BrDu and increase cell proliferation.

[0308] The results are shown in FIGS. 1-100 and Table 1 below.

TABLE-US-00006 FIGURE NO SEQ ID NO: INCREASE IN PROLIFERATION FIGURE NO SEQ ID NO: INCREASE IN PROLIFERATION 1 121 48% 29 98 49% 2 105 40% 30 454 38% 3 249 30% 31 85 35% 4 226 30% 32 453 25% 5 84 20% 33 158 21% 6 330 18% 34 464 18% 7 181 33% 35 73 16% 8 83 32% 36 359 15% 9 247 28% 37 124 15% 10 97 26% 38 112 15% 11 74 29% 39 733 12 40 728 13 168 41 727 14 151 42 730 15 470 119% 43 731 16 257 118% 44 148 17 256 117% 45 343 18 457 114% 46 345 19 499 113% 47 484 20 253 112% 48 729 21 222 110% 49 456 22 272 97% 50 494 23 252 111% 51 723 24 248 86% 52 722 25 472 77% 53 498 26 365 58% 54 475 13% 27 502 68% 55 718 28 496 51% 56 337 8% 57 500 6% 79 463 100% 58 717 80 465 96% 59 297 81 467 90% 60 340 82 461 85% 61 719 83 341 83% 62 726 84 468 82% 63 725 85 285 81% 64 724 86 496 81% 65 720 87 146 80% 66 721 88 478 76% 67 503 125% 89 452 76% 68 474 121% 90 495 68% 69 504 119% 91 403 51% 70 114 119% 92 455 47% 71 505 118% 93 270 47% 72 482 113% 94 501 43% 73 479 106% 95 473 41% 74 477 81% 96 39% 75 410 73% 97 471 38% 76 475 69% 98 460 38% 77 497 58% 99 93 26% 78 480 102% 100 462 15%

[0309] FIG. 1 shows an increase in HGF cell proliferation of 48% when incubated with SEQ ID NO: 121.

[0310] FIG. 2 shows an increase in HGF cell proliferation of 40% when incubated with SEQ ID NO: 105.

[0311] FIG. 3 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID NO: 249.

[0312] FIG. 4 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID NO: 226.

[0313] FIG. 5 shows an increase in HGF cell proliferation of 20% when incubated with SEQ ID NO: 84.

[0314] FIG. 6 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID NO: 330.

[0315] FIG. 7 shows an increase in HGF cell proliferation of 33% when incubated with SEQ ID NO: 181.

[0316] FIG. 8 shows an increase in HGF cell proliferation of 32% when incubated with SEQ ID NO: 83.

[0317] FIG. 9 shows an increase in HGF cell proliferation of 28% when incubated with SEQ ID NO: 247.

[0318] FIG. 10 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID NO: 97.

[0319] FIG. 11 shows an increase in HGF cell proliferation of 29% when incubated with SEQ ID NO: 74.

[0320] FIG. 15 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 470.

[0321] FIG. 16 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID NO: 257.

[0322] FIG. 17 shows an increase in HGF cell proliferation of 117% when incubated with SEQ ID NO: 256.

[0323] FIG. 18 shows an increase in HGF cell proliferation of 114% when incubated with SEQ ID NO: 457.

[0324] FIG. 19 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID NO: 499.

[0325] FIG. 20 shows an increase in HGF cell proliferation of 112% when incubated with SEQ ID NO: 253.

[0326] FIG. 21 shows an increase in HGF cell proliferation of 110% when incubated with SEQ ID NO: 222.

[0327] FIG. 22 shows an increase in HGF cell proliferation of 97% when incubated with SEQ ID NO: 272.

[0328] FIG. 23 shows an increase in HGF cell proliferation of 111% when incubated with SEQ ID NO: 252.

[0329] FIG. 24 shows an increase in HGF cell proliferation of 86% when incubated with SEQ ID NO: 248.

[0330] FIG. 25 shows an increase in HGF cell proliferation of 77% when incubated with SEQ ID NO: 472.

[0331] FIG. 26 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID NO: 365.

[0332] FIG. 27 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID NO: 502.

[0333] FIG. 28 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID NO: 496.

[0334] FIG. 29 shows an increase in HGF cell proliferation of 49% when incubated with SEQ ID NO: 98.

[0335] FIG. 30 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 454.

[0336] FIG. 31 shows an increase in HGF cell proliferation of 35% when incubated with SEQ ID NO: 85.

[0337] FIG. 32 shows an increase in HGF cell proliferation of 25% when incubated with SEQ ID NO: 453.

[0338] FIG. 33 shows an increase in HGF cell proliferation of 21% when incubated with SEQ ID NO: 158.

[0339] FIG. 34 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID NO: 464.

[0340] FIG. 35 shows an increase in HGF cell proliferation of 16% when incubated with SEQ ID NO: 73.

[0341] FIG. 36 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 359.

[0342] FIG. 37 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 124.

[0343] FIG. 38 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 112.

[0344] FIG. 54 shows an increase in HGF cell proliferation of 13% when incubated with SEQ ID NO: 475.

[0345] FIG. 56 shows an increase in HGF cell proliferation of 8% when incubated with SEQ ID NO: 337.

[0346] FIG. 57 shows an increase in HGF cell proliferation of 6% when incubated with SEQ ID NO: 500.

[0347] FIG. 67 shows an increase in HGF cell proliferation of 125% when incubated with SEQ ID NO: 503.

[0348] FIG. 68 shows an increase in HGF cell proliferation of 121% when incubated with SEQ ID NO: 474.

[0349] FIG. 69 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 504.

[0350] FIG. 70 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 114.

[0351] FIG. 71 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID NO: 505.

[0352] FIG. 72 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID NO: 482.

[0353] FIG. 73 shows an increase in HGF cell proliferation of 106% when incubated with SEQ ID NO: 479.

[0354] FIG. 74 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 477.

[0355] FIG. 75 shows an increase in HGF cell proliferation of 73% when incubated with SEQ ID NO: 410.

[0356] FIG. 76 shows an increase in HGF cell proliferation of 69% when incubated with SEQ ID NO: 475.

[0357] FIG. 77 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID NO: 497.

[0358] FIG. 78 shows an increase in HGF cell proliferation of 102% when incubated with SEQ ID NO: 480.

[0359] FIG. 79 shows an increase in HGF cell proliferation of 100% when incubated with SEQ ID NO: 463.

[0360] FIG. 80 shows an increase in HGF cell proliferation of 96% when incubated with SEQ ID NO: 465.

[0361] FIG. 81 shows an increase in HGF cell proliferation of 90% when incubated with SEQ ID NO: 467.

[0362] FIG. 82 shows an increase in HGF cell proliferation of 85% when incubated with SEQ ID NO: 461.

[0363] FIG. 83 shows an increase in HGF cell proliferation of 83% when incubated with SEQ ID NO: 341.

[0364] FIG. 84 shows an increase in HGF cell proliferation of 82% when incubated with SEQ ID NO: 468.

[0365] FIG. 85 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 485.

[0366] FIG. 86 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 496.

[0367] FIG. 87 shows an increase in HGF cell proliferation of 80% when incubated with SEQ ID NO: 146.

[0368] FIG. 88 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID NO: 478.

[0369] FIG. 89 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID NO: 452.

[0370] FIG. 90 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID NO: 495.

[0371] FIG. 91 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID NO: 403.

[0372] FIG. 92 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID NO: 455.

[0373] FIG. 93 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID NO: 270.

[0374] FIG. 94 shows an increase in HGF cell proliferation of 43% when incubated with SEQ ID NO: 501.

[0375] FIG. 95 shows an increase in HGF cell proliferation of 41% when incubated with SEQ ID NO: 473.

[0376] FIG. 97 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 471.

[0377] FIG. 98 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 460.

[0378] FIG. 99 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID NO: 93.

[0379] FIG. 100 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 462.

Example 2 - Collagen Production Assay

[0380] Hydroxyproline in tissue preparations is a direct measure of the amount of collagen present. FIRELISA Human Hydroxyproline ELISA kit assay is designed to measure hydroxyproline in tissue or peptide compositions.

[0381] Human Dermal Fibroblasts (HDF Sigma 10605a) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

[0382] Following the initial 24 h incubation the cells were incubated with 5 .Math.g/ml, 1 .Math.g/ml or 0.1 .Math.g/ml synthetic peptide for 96 h respectively.

[0383] After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 .Math.l/ml of each supernatant was assayed using the FIRELISA Human Hydroxyproline ELISA kit. All steps were carried out according to the manufacturer’s instructions.

[0384] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content. The results are shown in FIGS. 102, 104, 106 and 109

Example 3 - Elastin Production Assay

[0385] Elastin is a highly elastic protein in connective tissue and allows many tissues in the body to resume their shape after stretching or contracting. FIRELISA Human Elastin ELISA kit assay is designed to measure Elastin in tissue or protein/peptide compositions.

[0386] Human Dermal Fibroblasts (HDF) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

[0387] Following the initial 24 h incubation the cells were incubated with 5 .Math.g/ml, 1 .Math.g/ml or 0.1 .Math.g/ml synthetic peptide for 96 h respectively.

[0388] After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 .Math.l/ml of each supernatant was assayed using the FIRELISA Human Elastin ELISA kit. All steps were carried out according to the manufacturer’s instructions.

[0389] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content.

[0390] The results are shown in FIGS. 101, 103, 105, 107, 108 and 109.

Example 4 - Elastin and Cell Proliferation Assays

[0391] TABLE-US-00007 Test items. Peptide 6 and Peptide 7 correspond to samples dissolved into DMSO 0.3% instead of water. Item Denomination Concentration Provider Nature Intertek reference Solubility Storage Peptide 1 E_280_PJ 20 .Math.M Nuritas Peptide 14-CHL- 0723-01 Water -80° C. Peptide 2 I_222two_IN 20 .Math.M Nuritas Peptide 14-CHL- 0723-02 Water Ambient Peptide 3 E_134_two_IN 20 .Math.M Nuritas Peptide 14-CHL- 0723-03 Water -80° C. Peptide 4 E_30two_IN 20 .Math.M Nuritas Peptide 14-CHL- 0723-04 Water -80° C. Peptide 5 E_121two_IN 20 .Math.M Nuritas Peptide 14-CHL- 0723-05 Water -80° C. Peptide 6 I_10two_IN 20 .Math.M Nuritas Peptide 14-CHL- 723-06 DMSO 0.3% -80° C. Peptide 7 I_41two_IN 20 .Math.M Nuritas Peptide 14-CHL- 0723-07 DMSO 0.3% -80° C. Peptide 8 E_41_PJ 10 .Math.M* Nuritas Peptide 14-CHL- 0723-08 Water -80° C. Composition P9 E _2_IN 500 .Math.g/mL Nuritas Composition of peptides 14-CHL- 0723-09 Water -80° C. Composition P10 I_2_IN 500 .Math.g/mL Nuritas Composition of peptides 14-CHL- 0723-10 Water -80° C.

Equipment

[0392] Incubator, Flow Laminar Chamber, Sterile Polished Plastic Rod, Pipettor, Maintenance medium, Plate 6 well, Plate 24 well.

Reagents

[0393] MTT, PBS, SDS, Formaldehyde, Xylene, Ethanol absolute, Dulbecco’s phosphate-buffered saline (DPBS), Metal Enhanced DAB substrate kit, ABC peroxidase staining kit, Citric acid, Sodium hydroxide 2N, Hydrogen peroxide 30%, Anti-Filaggrin, Anti-rabbit IgG-Biotin, Tween 20.

Test System

[0394] Nature: Human skin tissue 5 mm diameter [0395] Batch number: EXP004050B009 and EXP004050B011 [0396] Provider: Laboratoire Biopredic International — 8-18 rue Jean Pecker — 35000 Rennes -France. Tel: +33 (0)2.99.14.36.14 — Fax: +33 (0)2.99.54.44.72.

[0397] Certificates of analysis are present in Annex 1.

[0398] Two batches are used for the assay. Batch EXP004050B005 is used for experiment day 1, and Batch EXP004050B006 is used for experiment day 5.

Maintenance Medium

[0399] Maintenance Medium: Batch n°: MIL 218C [0400] Provider: Laboratoire Biopredic International — 8-18 rue Jean Pecker — 35000 Rennes -France.

Peptides Tested

[0401] TABLE-US-00008 P1: SEQ ID NO: 283

TABLE-US-00009 P2: SEQ ID NO: 246

TABLE-US-00010 P3: SEQ ID NO: 284

TABLE-US-00011 P4: RPYYSNAPQEIF (SEQ ID NO: 776)

TABLE-US-00012 P5: VLLEQQEQEPQH (SEQ ID NO: 777)

TABLE-US-00013 P6: SEQ ID NO: 245

TABLE-US-00014 P7: QQYGIAASPFLQSAA (SEQ ID NO: 778)

TABLE-US-00015 P8: SEQ ID NO: 42

Compositions Tested

[0402] P9 (14-CHL-0723-09) is the Pea composition (SEQ ID NOs: 50, 85, 74, 140, 82, 136, 189, 77, 169, 149, 171, 178, 143, 127, 190, 141, 147, 133, 186, 125, 122, 119, 87, 90, 86, 89, 138, 129, 123, 120, 117, 113, 110, 121, 105, 98, 55, 161, 19, 317, 135, 130, 146, 177, 160, 170, 188, 83, 78, 36, 96, 159, 26, 330, 168, 148, 184, 151, 151, 165, 114, 284) [0403] P10 (14-CHL-0723-010) is the Rice composition (SEQ ID NOs: 245, 246, 263, 250, 257, 259, 276, 255, 251, 264, 256, 266, 274, 270, 269, 356, 245, 380, 262, 258, 356, 218, 252, 358, 271, 253, 344, 275, 272, 226, 224, 220, 248, 261, 265, 373, 375, 247, 249, 363, 273, 343, 273, 362)

Application Method

[0404] Skin explants were prepared from abdominal plastic surgery. Some explants were delipidated with alcohol to obtain a dehydrated skin.

[0405] These explants were maintained in maintenance medium supplied by the provider Bioprédic International for 5 days. Test items are applied twice per day with 5 .Math.L per explant.

[0406] At the end of the test, viabilities controls are realized with the MTT on two explants, the third explant is fixed in the formaldehyde 4% for histology and cell staining.

[0407] For each time of analysis (D1 and D5), histologies on delipidated explants, treated explants with test items, the DMSO 0.3% control and water control, are performed.

[0408] After receipt in the laboratory, each skin explant in the maintenance medium is delipidated with 5 .Math.L alcohol during 3 hours.

[0409] After 3 hours, all skin explants are treated two per day with test items, and they are incubated at 37° C. +/- 2° C., 5% CO2 for 1 day or 5 days.

[0410] Integrity of the system is realized at day 1 and day 5 with a viability control with MTT.

Immunostaining

[0411] Histology is realized by the laboratory Gredeco and the immunostaining to elastin and Ki67 are realized by the same laboratory. Immunostaining to filaggrin is realized by the laboratory Intertek.

[0412] The detection of elastin (rabbit monoclonal antibody, clone P15502, LSBio) is performed using an immunoperoxidase technique two layers (ABC kit, Vector Laboratories) and revealed by AEC (3-amino-9 -ethylcarbazole). The immunohistochemical staining intensity in the elastic fibers is evaluated using a semi-quantitative histological score.

[0413] Epithelial proliferation was analyzed by immunohistochemistry using anti-Ki67 antibody. Immunodetection was performed using an indirect immunoperoxidase technique three layers, amplified (DAKO kit) and revealed by AEC (3-Amino-9-ethylcarbazole). Counting the number of labeled cells (keratinocytes of the basal layer of the epidermis) is performed and provides the total number of basal cells to calculate the % of labeled cells.

[0414] The specific staining of filaggrin is performed with an immunoperoxidase staining (ABC kit, Fisher). The intensity of immunohistochemical marker in the epidermis is evaluated relative to the negative control of the solvent (Water or DMSO 0.3%).

C: Results

Viability Control

[0415] The integrity control and the viability control are present in FIG. 1. These controls do allow to validate the assay system. The viability is > 50% for test items, and they do not show a cytotoxicity according to the test.

Immunostaining

Elastin Expression

[0416] The elastic fibers of the dermis were revealed by staining with the catechin and morphometrically quantified by analysis by computer-assisted image. The percentage area taken up by elastic fibers in the dermis was calculated in the dermis and the average superficial dermis. Results are presented in FIGS. 101, 105, 107, and 108.

TABLE-US-00016 Morphometric quantification of elastic fibers in the superficial dermis (%) and middle dermis. All samples dissolved in water except where indicated. Morphometric quantification of elastic fibers in the superficial dermis (%) Morphometric quantification of elastic fibers in the middle dermis (%) Conditions D1 D5 D1 D5 Dehydrated with alcohol and hydrated with water 4.31 4.9 5 5.83 Dehydrated 2.38 7.26 4.39 9.59 EGF (Epidermal Growth Factor) 10 ng/mL 3.64 5.61 5.68 6.61 Dehydrated with alcohol and hydrated with DMSO 0.3% 3.76 7.24 6 10.36 0723.01 4.45 10.21 7.59 10.17 0723.02 6.09 7.59 11.,75 9.08 0723.03 3 11.68 4.9 9 0723.04 3.28 8.94 5.22 9 0723.05 6.34 6.26 8.8 6.61 0723.06 (dissolved into DMSO 0.3% instead of water) 3.8 4.03 4.54 8.67 0723.07 (dissolved into DMSO 0.3% instead of water) 4 5.15 6.46 5.33 0723.08 2.7 5.32 3.52 7.27 0723.09 3.26 8.26 5.75 7.92 0723.10 4.1 8 5.73 8.34

[0417] Under the experimental conditions of the study, 0723-1 and 0723-3 samples show an increase by twice of elastic fibers in the superficial dermis compared to control water (Figure), and an increase in the middle dermis compared to the water control at D5.

[0418] The 0723-2 sample shows an increase doubled in the middle dermis at day 1 compared to control water and an increase at day 5.

Ki67 Expression

[0419] The results of the immunohistochemical analysis of Ki67 are reported in Table 4 and expressed as % of labelled at the basal layer of the epidermis. The FIG. 115 shows the percentage of Ki 67 cells compared to negative controls (water or DMSO). Immunohistochemical analysis of mitotic activity is shown in annex 4 with a reminder of the average for each analysed conditions.

TABLE-US-00017 % of Ki67 positive cells in the basal layer of the epidermis. All samples dissolved in water except where indicated. Conditions D1 D5 Dehydrated with alcohol and hydrated with water 19.09 3.53 Dehydrated 17.05 1.76 EGF (Epidermal Growth Factor) 10 ng/mL 25.11 4.2 Dehydrated with alcohol and hydrated with DMSO 0.3% 17.2 2.61 0723.01 18.57 3.92 0723.02 19.61 6.73 0723.03 22.01 10.04 0723.04 14.97 11.36 0723.05 9.48 3.08 0723.06 (dissolved into DMSO 0.3% instead of water) 31.97 5.04 0723.07 (dissolved into DMSO 0.3% instead of water) 22.22 5.26 0723.08 27.83 5.72 0723.09 31.02 2.4 0723.10 31.94 3.57

[0420] Under the experimental conditions of the study, test item 0723-06, 0723-08, 0723-09 and 0723-010 show an increase in the number of mitotic cells compared to EGF at day 1. A decrease in the mitotic index was observed on day 5 compared to day 1 for all analysed conditions.

[0421] The decrease in this cell staining on day 5 is caused by the model. Indeed, after approximately 3 days cell turnover is exhausted on this model.

[0422] The invention is not limited to the embodiments hereinbefore described which may be varied in construction and detail without departing from the spirit of the invention.

[0423] SEQUENCES PROTEIN : P13918 — 2 — PEA

TABLE-US-00018 MAATTMKASFPLLMLMGISFLASVCVSSRSDPQNPFIFKSNKFQTLFENE NGHIRLLQKFDQRSKIFENLQNYRLLEYKSKPHTIFLPQHTDADYILVVL SGKAILTVLKPDDRNSFNLERGDTIKLPAGTIAYLVNRDDNEELRVLDLA IPVNRPGQLQSFLLSGNQNQQNYLSGFSKNILEASFNTDYEEIEKVLLEE HEKETQHRRSLKDKRQQSQEENVIVKLSRGQIEELSKNAKSTSKKSVSSE SEPFNLRSRGPIYSNEFGKFFEITPEKNPQLQDLDIFVNSVEIKEGSLLL PHYNSRAIVIVTVNEGKGDFELVGQRNENQQEQRKEDDEEEEQGEEEINK QVQNYKAKLSSGDVFVIPAGHPVAVKASSNLDLLGFGINAENNQRNFLAG DEDNVISQIQRPVKELAFPGSAQEVDRILENQKQSHFADAQPQQRERGSR ETRDRLSSV [SEQ ID NO: 1]

TABLE-US-00019 PEPTIDE : QNYLSGFSKNILE [SEQ ID NO: 15]

TABLE-US-00020 PEPTIDE : TIKLPAGTIAYLVNRDDNEE [SEQ ID NO: 16]

TABLE-US-00021 PEPTIDE : LAIPVNRPGQLQSFL [SEQ ID NO : 17]

TABLE-US-00022 PEPTIDE : AIPVNRPGQLQ [SEQ ID NO: 18 ]

TABLE-US-00023 PEPTIDE : PAGHPVAVK [SEQ ID NO: 19]

TABLE-US-00024 PEPTIDE : VQNYKAKLSSGDVFVIPAG [SEQ I D NO: 20]

TABLE-US-00025 PEPTIDE : NNQRNFLAGDEDNVISQIQRPVKE [ SEQ ID NO: 21]

TABLE-US-00026 PEPTIDE : INKQVQNYKAKLSSGDVFVIPAG [S EQ ID NO: 22]

TABLE-US-00027 PEPTIDE : LAIPVNRPGQ [SEQ ID NO: 23]

TABLE-US-00028 PEPTIDE : NFLAGDEDNVISQIQRPVKE [SEQ ID NO: 24]

TABLE-US-00029 PEPTIDE : DLAIPVNRPGQLQSF [SEQ ID NO : 25]

TABLE-US-00030 PEPTIDE : VIPAGHPVAVK [SEQ ID NO: 26 ]

TABLE-US-00031 PEPTIDE : DTIKLPAGTIAYLVNRDDNEE [SEQ ID NO: 27]

TABLE-US-00032 PEPTIDE : LAIPVNRPGQLQSF [SEQ ID NO: 28]

TABLE-US-00033 PEPTIDE : KQVQNYKAKLSSGDVFVIPAG [SEQ ID NO: 29]

TABLE-US-00034 PEPTIDE : RGDTIKLPAGTIAYLVNRDDNEE [S EQ ID NO: 30]

TABLE-US-00035 PEPTIDE : FLAGDEDNVISQIQRPVKE [SEQ I D NO: 31]

TABLE-US-00036 PEPTIDE : LAIPVNRPGQLQS [SEQ ID NO: 32]

TABLE-US-00037 PEPTIDE : VLDLAIPVNRPGQLQ [SEQ ID NO : 33]

TABLE-US-00038 PEPTIDE : DLAIPVNRPGQLQ [SEQ ID NO: 34]

TABLE-US-00039 PEPTIDE : VFVIPAGHPVAVK [SEQ ID NO: 35]

TABLE-US-00040 PEPTIDE : TIFLPQHTDADYILVVLSGK [SEQ ID NO: 36]

TABLE-US-00041 PEPTIDE : NQRNFLAGDEDNVISQIQRPVKE [S EQ ID NO: 37]

TABLE-US-00042 PEPTIDE : LAIPVNRPGQLQ [SEQ ID NO: 3 8]

TABLE-US-00043 PEPTIDE : HPVAVKASSNLDLLGFG [SEQ ID NO: 39]

TABLE-US-00044 PEPTIDE : LAIPVNRPGQL [SEQ ID NO: 40 ]

TABLE-US-00045 PEPTIDE : DLAIPVNRPGQL [SEQ ID NO: 4 1]

TABLE-US-00046 PEPTIDE : SKPHTIFLPQHTDADYILVVLSGK [ SEQ ID NO: 42]

TABLE-US-00047 PEPTIDE : FVIPAGHPVAVK [SEQ ID NO: 4 3]

TABLE-US-00048 PEPTIDE : DLAIPVNRPGQLQS [SEQ ID NO: 44]

TABLE-US-00049 PEPTIDE : SGDVFVIPAGHPVAVKASSNLD [SE Q ID NO: 45]

TABLE-US-00050 PEPTIDE : AIPVNRPGQLQSF [SEQ ID NO: 46]

TABLE-US-00051 PEPTIDE : ELAFPGSAQEVDR [SEQ ID NO: 47]

TABLE-US-00052 PEPTIDE : LAIPVNRPGQLQSFLLSG [SEQ ID NO: 48]

TABLE-US-00053 PEPTIDE : VFVIPAGHPVAVKASSNLDLLGFG [ SEQ ID NO: 49]

TABLE-US-00054 PEPTIDE : AGHPVAVK [SEQ ID NO: 50]

TABLE-US-00055 PEPTIDE : HPVAVKASSNLDLLGFGINAE [SEQ ID NO: 51]

TABLE-US-00056 PEPTIDE : LAIPVNRPGQLQSFLLSGNQNQ [SE Q ID NO: 52]

TABLE-US-00057 PEPTIDE : SGDVFVIPAG [SEQ ID NO: 53]

TABLE-US-00058 PEPTIDE : GSLLLPHYNSRAIVIVTVNE [SEQ ID NO: 54]

TABLE-US-00059 PEPTIDE : NFLAGDEDNVISQIQRPVK [SEQ I D NO: 55]

TABLE-US-00060 PEPTIDE : SGDVFVIPAGHPVA [SEQ ID NO: 56]

TABLE-US-00061 PEPTIDE : GSLLLPHYNSRAIVIV [SEQ ID N O: 57]

TABLE-US-00062 PEPTIDE : RGDTIKLPAGTIAYLVNRDD [SEQ ID NO: 58]

TABLE-US-00063 PEPTIDE : SGDVFVIPAGHPVAVK [SEQ ID N O: 59]

TABLE-US-00064 PEPTIDE : LSSGDVFVIPAGHPVAVK [SEQ ID NO: 60]

TABLE-US-00065 PEPTIDE : LDLAIPVNRPGQL [SEQ ID NO: 61]

TABLE-US-00066 PEPTIDE : AIPVNRPGQL [SEQ ID NO: 62]

TABLE-US-00067 PEPTIDE : LAIPVNRPGQLQSFLL [SEQ ID N O: 63]

TABLE-US-00068 PEPTIDE : PHTIFLPQHTDADYILVVLSGK [SE Q ID NO: 64]

TABLE-US-00069 PEPTIDE : VFVIPAGHPVAVKASSNLD [SEQ I D NO: 65]

TABLE-US-00070 PEPTIDE : LAIPVNRPGQLQSFLLS [SEQ ID NO: 66]

TABLE-US-00071 PEPTIDE : VLDLAIPVNRPGQLQSF [SEQ ID NO: 67]

TABLE-US-00072 PEPTIDE : AIPVNRPGQLQS [SEQ ID NO: 6 8]

TABLE-US-00073 PEPTIDE : DTIKLPAGTIAYLVNRDDNE [SEQ ID NO: 69]

TABLE-US-00074 PEPTIDE : NYKAKLSSGDVFVIPAG [SEQ ID NO: 70]

TABLE-US-00075 PEPTIDE : GKAILTVLKPDDRNSFNLE [SEQ I D NO: 71]

TABLE-US-00076 PEPTIDE : YKSKPHTIFLPQHTDAD [SEQ ID NO: 72]

TABLE-US-00077 PEPTIDE : ASSNLDLLGFG [SEQ ID NO: 73 ]

TABLE-US-00078 PEPTIDE : DEEEEQGEEEINK [SEQ ID NO: 74]

TABLE-US-00079 PEPTIDE : YKSKPHTIFLPQHTD [SEQ ID NO : 75]

TABLE-US-00080 PEPTIDE : VLDLAIPVNR [SEQ ID NO: 76]

TABLE-US-00081 PEPTIDE : FFEITPEKNPQLQDLDIFVNSVEIK [SEQ ID NO: 77]

TABLE-US-00082 PEPTIDE : TIFLPQHTDADYIL [SEQ ID NO: 78]

TABLE-US-00083 PEPTIDE : SFLLSGNQNQQNYLSG [SEQ ID N O: 79]

TABLE-US-00084 PEPTIDE : SFLLSGNQNQQNYLSGFS [SEQ ID NO: 80]

TABLE-US-00085 PEPTIDE : NQQEQRKEDDEEEEQGEEE [SEQ I D NO: 81]

TABLE-US-00086 PEPTIDE : EEQGEEEINK [SEQ ID NO: 82]

TABLE-US-00087 PEPTIDE : SRGPIYSNE [SEQ ID NO: 83]

TABLE-US-00088 PEPTIDE : EDDEEEEQGEEEINK [SEQ ID NO : 84]

TABLE-US-00089 PEPTIDE : DDEEEEQGEEEINK [SEQ ID NO: 85]

TABLE-US-00090 PEPTIDE : KEDDEEEEQGEEEIN [SEQ ID NO : 86]

TABLE-US-00091 PEPTIDE : KEDDEEEEQGEE [SEQ ID NO: 8 7]

TABLE-US-00092 PEPTIDE : QRKEDDEEEEQGEEE [SEQ ID NO : 88]

TABLE-US-00093 PEPTIDE : KEDDEEEEQGEEEINK [SEQ ID N O: 89]

TABLE-US-00094 PEPTIDE : KEDDEEEEQGEEE [SEQ ID NO: 90]

[0424] PROTEIN : Q9M3X6 - 3 - PEA

TABLE-US-00095 MATTIKSRFPLLLLLGIIFLASVVCVTYANYDEGSEPRVPAQRERGRQEG EKEEKRHGEWRPSYEKEEDEEEGQRERGRQEGEKEEKRHGEWRPSYEKQE DEEEKQKYRYQREKEDEEEKQKYQYQREKKEQKEVQPGRERWEREEDEEQ VDEEWRGSQRREDPEERARLRHREERTKRDRRHQREGEEEERSSESQERR NPFLFKSNKFLTLFENENGHIRLLQRFDKRSDLFENLQNYRLVEYRAKPH TIFLPQHIDADLILVVLSGKAILTVLSPNDRNSYNLERGDTIKLPAGTTS YLVNQDDEEDLRLVDLVIPVNGPGKFEAFDLAKNKNQYLRGFSKNILEAS YNTRYETIEKVLLEEQEKDRKRRQQGEETDAIVKVSREQIEELKKLAKSS SKKSLPSEFEPINLRSHKPEYSNKFGKLFEITPEKKYPQLQDLDLFVSCV EINEGALMLPHYNSRAIVVLLVNEGKGNLELLGLKNEQQEREDRKERNNE VQRYEARLSPGDVVIIPAGHPVAITASSNLNLLGFGINAENNERNFLSGS DDNVISQIENPVKELTFPGSVQEINRLIKNQKQSHFANAEPEQKEQGSQG KRSPLSSILGTFY [SEQ ID NO: 2]

TABLE-US-00096 PEPTIDE : HPVAITASSNLNLLG [SEQ ID NO : 91]

TABLE-US-00097 PEPTIDE : ASSNLNLLGFG [SEQ ID NO: 92 ]

TABLE-US-00098 PEPTIDE : ITASSNLNLLGFG [SEQ ID NO: 93]

TABLE-US-00099 PEPTIDE : ITASSNLNLLGFGINAE [SEQ ID NO: 94]

TABLE-US-00100 PEPTIDE : SSNLNLLGFG [SEQ ID NO: 95]

TABLE-US-00101 PEPTIDE : VDLVIPVNGPGKF [SEQ ID NO: 96]

TABLE-US-00102 PEPTIDE : LVIPVNGPGKFE [SEQ ID NO: 9 7]

TABLE-US-00103 PEPTIDE : LVIPVNGPGKFEA [SEQ ID NO: 98]

TABLE-US-00104 PEPTIDE : LRLVDLVIPVNGPGKFE [SEQ ID NO: 99]

TABLE-US-00105 PEPTIDE : YRAKPHTIFLPQHIDAD [SEQ ID NO: 100]

TABLE-US-00106 PEPTIDE : HPVAITASSNLNLLGFGINAE [SEQ ID NO: 101]

TABLE-US-00107 PEPTIDE : SNLNLLGFG [SEQ ID NO: 102]

TABLE-US-00108 PEPTIDE : HPVAITASSNLNLLGFGINAENNE [ SEQ ID NO: 103]

TABLE-US-00109 PEPTIDE : LVDLVIPVNGPGKFE [SEQ ID NO : 104]

TABLE-US-00110 PEPTIDE : LVIPVNGPGKF [SEQ ID NO: 10 5]

TABLE-US-00111 PEPTIDE : TIKLPAGTTSYLVNQDDE [SEQ ID NO: 106]

TABLE-US-00112 PEPTIDE : DLRLVDLVIPVNGPGKFE [SEQ ID NO: 107]

TABLE-US-00113 PEPTIDE : EDLRLVDLVIPVNGPGKFE [SEQ I D NO: 108]

TABLE-US-00114 PEPTIDE : HPVAITASSNLNLLGFG [SEQ ID NO: 109]

TABLE-US-00115 PEPTIDE : LVDLVIPVNGPGKFEAFDLAK [SEQ ID NO: 110]

TABLE-US-00116 PEPTIDE : DNVISQIENPVKE [SEQ ID NO: 111]

TABLE-US-00117 PEPTIDE : VVIIPAGHPVAITASSNLNLLGFG [ SEQ ID NO: 112]

TABLE-US-00118 PEPTIDE : LVDLVIPVNGPGKFEAF [SEQ ID NO: 113]

TABLE-US-00119 PEPTIDE : YPQLQDLDL [SEQ ID NO: 114]

TABLE-US-00120 PEPTIDE : VIPVNGPGKF [SEQ ID NO: 115 ]

TABLE-US-00121 PEPTIDE : SKKSLPSE [SEQ ID NO: 116]

TABLE-US-00122 PEPTIDE : LPQHIDADLILVVLSGK [SEQ ID NO: 117]

TABLE-US-00123 PEPTIDE : RGDTIKLPAGTTSYLVNQD [SEQ I D NO: 118]

TABLE-US-00124 PEPTIDE : IPVNGPGKF [SEQ ID NO: 119]

TABLE-US-00125 PEPTIDE : LPQHIDADL [SEQ ID NO: 120]

TABLE-US-00126 PEPTIDE : LVIPVNGPGK [SEQ ID NO: 121 ]

TABLE-US-00127 PEPTIDE : IFLPQHIDAD [SEQ ID NO: 122 ]

TABLE-US-00128 PEPTIDE : LPQHIDAD [SEQ ID NO: 123]

TABLE-US-00129 PEPTIDE : VIPVNGPGK [SEQ ID NO: 124]

TABLE-US-00130 PEPTIDE : IFLPQHIDA [SEQ ID NO: 125]

TABLE-US-00131 PEPTIDE : TIKLPAGTTSYLVNQDDEE [SEQ I D NO: 126]

TABLE-US-00132 PEPTIDE : HGEWRPSYEKEEDEEEGQRER [SEQ ID NO: 127]

TABLE-US-00133 PEPTIDE : EKRHGEWRPSYEKEEDEEEGQRE [S EQ ID NO: 128]

TABLE-US-00134 PEPTIDE : LPAGTTSYLVNQDDEEDLR [SEQ I D NO: 129]

TABLE-US-00135 PEPTIDE : PSYEKEEDEEEGQRER [SEQ ID N O: 130]

TABLE-US-00136 PEPTIDE : EKRHGEWRPSYE [SEQ ID NO: 1 31]

TABLE-US-00137 PEPTIDE : TIKLPAGTTSYLVNQDDEED [SEQ ID NO: 132]

TABLE-US-00138 PEPTIDE : HGEWRPSYEKQEDEEEK [SEQ ID NO: 133]

TABLE-US-00139 PEPTIDE : EWRPSYEKEEDEEE [SEQ ID NO: 134]

TABLE-US-00140 PEPTIDE : PSYEKEEDEEEGQR [SEQ ID NO: 135]

TABLE-US-00141 PEPTIDE : EKEEDEEEGQR [SEQ ID NO: 13 6]

TABLE-US-00142 PEPTIDE : EWRPSYEKEEDEEEGQRE [SEQ ID NO: 137]

TABLE-US-00143 PEPTIDE : KEEDEEEGQR [SEQ ID NO: 138 ]

TABLE-US-00144 PEPTIDE : VQPGRERWEREEDEEQVDE [SEQ I D NO: 139]

TABLE-US-00145 PEPTIDE : DVVIIPAGHPVA [SEQ ID NO: 1 40]

TABLE-US-00146 PEPTIDE : HGEWRPSYEKQEDE [SEQ ID NO: 141]

TABLE-US-00147 PEPTIDE : EEDEEEGQR [SEQ ID NO: 142]

TABLE-US-00148 PEPTIDE : HGEWRPSYEKEEDEEEGQR [SEQ I D NO: 143]

TABLE-US-00149 PEPTIDE : EEWRGSQRREDPEE [SEQ ID NO: 144]

TABLE-US-00150 PEPTIDE : REEDEEQVDEEWRGSQRREDPEE [S EQ ID NO: 145]

TABLE-US-00151 PEPTIDE : RHGEWRPSY [SEQ ID NO: 146]

TABLE-US-00152 PEPTIDE : HGEWRPSYEKQEDEE [SEQ ID NO : 147]

TABLE-US-00153 PEPTIDE : VVIIPAGHPVA [SEQ ID NO: 14 8]

TABLE-US-00154 PEPTIDE : HGEWRPSYE [SEQ ID NO: 149]

TABLE-US-00155 PEPTIDE : KEEDEEEGQRER [SEQ ID NO: 1 50]

TABLE-US-00156 PEPTIDE : VVIIPAGHPVAIT [SEQ ID NO: 151]

TABLE-US-00157 PEPTIDE : EKRHGEWRPSYEKEEDE [SEQ ID NO: 152]

TABLE-US-00158 PEPTIDE : QVDEEWRGSQRREDPEE [SEQ ID NO: 153]

TABLE-US-00159 PEPTIDE : GDTIKLPAGTTSYLVNQDDEEDLR [ SEQ ID NO: 154]

TABLE-US-00160 PEPTIDE : GSEPRVPAQRE [SEQ ID NO: 15 5]

TABLE-US-00161 PEPTIDE : EEKRHGEWRPSYEKE [SEQ ID NO : 156]

TABLE-US-00162 PEPTIDE : EWRPSYEKEEDEE [SEQ ID NO: 157]

TABLE-US-00163 PEPTIDE : NYDEGSEPRVPAQRE [SEQ ID NO : 158]

TABLE-US-00164 PEPTIDE : VIIPAGHPVAIT [SEQ ID NO: 1 59]

TABLE-US-00165 PEPTIDE : RHGEWRPSYEK [SEQ ID NO: 16 0]

TABLE-US-00166 PEPTIDE : NYDEGSEPR [SEQ ID NO: 161]

TABLE-US-00167 PEPTIDE : WRPSYEKEEDEE [SEQ ID NO: 1 62]

TABLE-US-00168 PEPTIDE : WRPSYEKQEDEEE [SEQ ID NO: 163]

TABLE-US-00169 PEPTIDE : EKRHGEWRPSYEKQEDEEE [SEQ I D NO: 164]

TABLE-US-00170 PEPTIDE : VVIIPAGHPVAITA [SEQ ID NO: 165]

TABLE-US-00171 PEPTIDE : KRHGEWRPSYE [SEQ ID NO: 16 6]

TABLE-US-00172 PEPTIDE : GSDDNVISQIENPVKE [SEQ ID N O: 167]

TABLE-US-00173 PEPTIDE : VVIIPAGHPV [SEQ ID NO: 168 ]

TABLE-US-00174 PEPTIDE : HGEWRPSY [SEQ ID NO: 169]

TABLE-US-00175 PEPTIDE : RPSYEKEEDEEEGQR [SEQ ID NO : 170]

TABLE-US-00176 PEPTIDE : HGEWRPSYEK [SEQ ID NO: 171 ]

TABLE-US-00177 PEPTIDE : KRHGEWRPSYEKEE [SEQ ID NO: 172]

TABLE-US-00178 PEPTIDE : VVIIPAGHPVAITAS [SEQ ID NO : 173]

TABLE-US-00179 PEPTIDE : RGDTIKLPAGTTSYLVNQDDEED [S EQ ID NO: 174]

TABLE-US-00180 PEPTIDE : KRHGEWRPSYEKQEDEEE [SEQ ID NO: 175]

TABLE-US-00181 PEPTIDE : DEEQVDEEWRGSQRREDPEE [SEQ ID NO: 176]

TABLE-US-00182 PEPTIDE : RHGEWRPSYE [SEQ ID NO: 177 ]

TABLE-US-00183 PEPTIDE : HGEWRPSYEKE [SEQ ID NO: 17 8]

TABLE-US-00184 PEPTIDE : KRHGEWRPSYEKEEDEEE [SEQ ID NO: 179]

TABLE-US-00185 PEPTIDE : EKRHGEWRPSYEKEEDEEE [SEQ I D NO: 180]

TABLE-US-00186 PEPTIDE : TIKLPAGTTSYLVNQDDEEDLRLVD [SEQ ID NO: 181]

TABLE-US-00187 PEPTIDE : WRPSYEKEEDEEEGQRE [SEQ ID NO: 182]

TABLE-US-00188 PEPTIDE : KRHGEWRPSYEKEEDEE [SEQ ID NO: 183]

TABLE-US-00189 PEPTIDE : VVIIPAGHPVAI [SEQ ID NO: 1 84]

TABLE-US-00190 PEPTIDE : EWRGSQRREDPEE [SEQ ID NO: 185]

TABLE-US-00191 PEPTIDE : HGEWRPSYEKQEDEEEKQK [SEQ I D NO: 186]

TABLE-US-00192 PEPTIDE : SGSDDNVISQIENPVKE [SEQ ID NO: 187]

TABLE-US-00193 PEPTIDE : RPSYEKEEDEEEGQRER [SEQ ID NO: 188]

TABLE-US-00194 PEPTIDE : EKEEDEEEGQRER [SEQ ID NO: 189]

TABLE-US-00195 PEPTIDE : HGEWRPSYEKQ [SEQ ID NO: 19 0]

TABLE-US-00196 PEPTIDE : WRPSYEKEEDEEE [SEQ ID NO: 191]

TABLE-US-00197 PEPTIDE : LAKNKNQYLRGFS [SEQ ID NO: 192]

TABLE-US-00198 PEPTIDE : NKNQYLRGFS [SEQ ID NO: 193 ]

TABLE-US-00199 PEPTIDE : LRGFSKNILE [SEQ ID NO: 194 ]

TABLE-US-00200 PEPTIDE : LAKNKNQYLRGFSKN [SEQ ID NO : 195]

TABLE-US-00201 PEPTIDE : TVLSPNDRNSY [SEQ ID NO: 19 6]

TABLE-US-00202 PEPTIDE : QYLRGFSKNILE [SEQ ID NO: 1 97]

TABLE-US-00203 PEPTIDE : GKAILTVLSPNDRNSYNLE [SEQ I D NO: 198]

TABLE-US-00204 PEPTIDE : RGFSKNILE [SEQ ID NO: 199]

TABLE-US-00205 PEPTIDE : NKNQYLRGFSKNILE [SEQ ID NO : 200]

TABLE-US-00206 PEPTIDE : ASSNLNLLGFGINAE [SEQ ID NO : 201]

TABLE-US-00207 PEPTIDE : ASSNLNLLGF [SEQ ID NO: 202 ]

TABLE-US-00208 PEPTIDE : LAKNKNQYLRGFSK [SEQ ID NO: 203]

TABLE-US-00209 PEPTIDE : RGDTIKLPAGTTSYLVNQDDEE [SE Q ID NO: 204]

TABLE-US-00210 PEPTIDE : ARLSPGDVVIIPAGHPVAITASSN [ SEQ ID NO: 205]

TABLE-US-00211 PEPTIDE : VQRYEARLSPGD [SEQ ID NO: 2 06]

TABLE-US-00212 PEPTIDE : ARLSPGDVVIIPAGHPVAIT [SEQ ID NO: 207]

TABLE-US-00213 PEPTIDE : RGDTIKLPAGTTSYLVNQDDE [SEQ ID NO: 208]

TABLE-US-00214 PEPTIDE : ARLSPGDVVIIPAGHPVA [SEQ ID NO: 209]

TABLE-US-00215 PEPTIDE : GALMLPHYNSRAIVVLLVNE [SEQ ID NO: 210]

TABLE-US-00216 PEPTIDE : ARLSPGDVVIIPAGHPVAITASS [S EQ ID NO: 211]

TABLE-US-00217 PEPTIDE : LSPGDVVIIPAGHPVAITASSNLNLL GFGINAENNER [SEQ ID NO: 212]

TABLE-US-00218 PEPTIDE : ARLSPGDVVIIPAGHPVAITAS [SE Q ID NO: 213]

TABLE-US-00219 PEPTIDE : LSPGDVVIIPAGHPVAITASSNL [S EQ ID NO: 214]

TABLE-US-00220 PEPTIDE : ARLSPGDVVIIPAGHPVAITA [SEQ ID NO: 215]

[0425] PROTEIN : Q0DEV5 - 5 - RICE

TABLE-US-00221 MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSV TTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEMAPWSKTGG LGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERV RFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKIYGPDTGVDYKDNQMRFSL LCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQP NGIYRNAKVAFCIHNISYQGRFAFEDYPELNLSERFRSSFDFIDGYDTPV EGRKINWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITG IVNGMDVSEWDPSKDKYITAKYDATTAIEAKALNKEALQAEAGLPVDRKI PLIAFIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSME EKYPGKVRAVVKFNAPLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTP CACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKV VGTPAYEEMVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAP LAKENVAAP [SEQ ID NO: 3]

TABLE-US-00222 PEPTIDE : NWENVLLGLGVAGSAPGIEGDEIAPL AK [SEQ ID NO: 216]

TABLE-US-00223 PEPTIDE : YDQYKDAWDTSVVAEIK [SEQ ID NO: 217]

TABLE-US-00224 PEPTIDE : SSFDFIDGYDTPVEGR [SEQ ID N O: 218]

TABLE-US-00225 PEPTIDE : GPDTGVDYKDNQM [SEQ ID NO: 219]

TABLE-US-00226 PEPTIDE : ILNLNNNPYFK [SEQ ID NO: 22 0]

TABLE-US-00227 PEPTIDE : VVGTPAYEE [SEQ ID NO: 221]

TABLE-US-00228 PEPTIDE : IDGYDTPVEGR [SEQ ID NO: 22 2]

TABLE-US-00229 PEPTIDE : VVGTPAYE [SEQ ID NO: 223]

TABLE-US-00230 PEPTIDE : IYGPDTGVDYK [SEQ ID NO: 22 4]

TABLE-US-00231 PEPTIDE : VAGSAPGIEGDE [SEQ ID NO: 2 25]

TABLE-US-00232 PEPTIDE : IYGPDTGVDYKDNQMR [SEQ ID N O: 226]

TABLE-US-00233 PEPTIDE : VVGTPAYEEMVR [SEQ ID NO: 2 27]

TABLE-US-00234 PEPTIDE : DFIDGYDTPVEGR [SEQ ID NO: 228]

TABLE-US-00235 PEPTIDE : LGLGVAGSAPGIEGDEIAPLAK [SE Q ID NO: 229]

TABLE-US-00236 PEPTIDE : FNAPLAHLIMAGADVLAVPSR [SEQ ID NO: 230]

TABLE-US-00237 PEPTIDE : LGLGVAGSAPGIEGDE [SEQ ID N O: 231]

TABLE-US-00238 PEPTIDE : LGLGVAGSAPGIEGDEIAPL [SEQ ID NO: 232]

TABLE-US-00239 PEPTIDE : VLTVSPYYAEELISGIAR [SEQ ID NO: 233]

TABLE-US-00240 PEPTIDE : EALQAEAGLPVDR [SEQ ID NO: 234]

TABLE-US-00241 PEPTIDE : LGLGVAGSAPGIEGD [SEQ ID NO : 235]

TABLE-US-00242 PEPTIDE : IMAGADVLAVPSR [SEQ ID NO: 236]

TABLE-US-00243 PEPTIDE : GLGVAGSAPGIEGDE [SEQ ID NO : 237]

TABLE-US-00244 PEPTIDE : EALQAEAGLPVDRK [SEQ ID NO: 238]

TABLE-US-00245 PEPTIDE : TGGLGDVLGGLPPAMAANGHR [SEQ ID NO: 239]

TABLE-US-00246 PEPTIDE : LEEQKGPDVMA [SEQ ID NO: 24 0]

TABLE-US-00247 PEPTIDE : LGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 241]

TABLE-US-00248 PEPTIDE : GLGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 242]

TABLE-US-00249 PEPTIDE : TGGLGDVLGGLPPAM [SEQ ID NO : 243]

TABLE-US-00250 PEPTIDE : NVLLGLGVAGSAPGIEGDE [SEQ I D NO: 244]

[0426] PROTEIN : P14323 - 6- RICE

TABLE-US-00251 MASSVFSRFSIYFCVLLLCHGSMAQLFNPSTNPWHSPRQGSFRECRFDRL QAFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLLVPRYTN IPGVVYIIQGRGSMGLTFPGCPATYQQQFQQFSSQGQSQSQKFRDEHQKI HQFRQGDIVALPAGVAHWFYNDGDAPIVAVYVYDVNNNANQLEPRQKEFL LAGNNNRAQQQQVYGSSIEQHSGQNIFSGFGVEMLSEALGINAVAAKRLQ SQNDQRGEIIHVKNGLQLLKPTLTQQQEQAQAQDQYQQVQYSERQQTSSR WNGLEENFCTIKVRVNIENPSRADSYNPRAGRITSVNSQKFPILNLIQMS ATRVNLYQNAILSPFWNVNAHSLVYMIQGRSRVQVVSNFGKTVFDGVLRP GQLLIIPQHYAVLKKAEREGCQYIAIKTNANAFVSHLAGKNSVFRALPVD VVANAYRISREQARSLKNNRGEEHGAFTPRFQQQYYPGLSNESESETSE [SEQ ID NO: 4]

TABLE-US-00252 PEPTIDE : TVFDGVLRPGQL [SEQ ID NO: 2 45]

TABLE-US-00253 PEPTIDE : RLQSQNDQRGEIIHVK [SEQ ID N O: 246]

[0427] PROTEIN : P29835 - 5 - RICE

TABLE-US-00254 MASKVVFFAAALMAAMVAISGAQLSESEMRFRDRQCQREVQDSPLDACRQ VLDRQLTGRERFQPMFRRPGALGLRMQCCQQLQDVSRECRCAAIRRMVRS YEESMPMPLEQGWSSSSSEYYGGEGSSSEQGYYGEGSSEEGYYGEQQQQP GMTRVRLTRARQYAAQLPSMCRVEPQQCSIFAAGQY [SEQ ID NO: 5 ]

TABLE-US-00255 PEPTIDE : EGYYGEQQQQPGMTR [SEQ ID NO : 247]

TABLE-US-00256 PEPTIDE : GYYGEQQQQPGMTR [SEQ ID NO: 248]

TABLE-US-00257 PEPTIDE : EEGYYGEQQQQPGMTR [SEQ ID N O: 249]

TABLE-US-00258 PEPTIDE : YYGGEGSSSEQGYYGEGSSE [SEQ ID NO: 250]

TABLE-US-00259 PEPTIDE : YGGEGSSSEQGYYGEGSSE [SEQ I D NO: 251]

TABLE-US-00260 PEPTIDE : SSEEGYYGEQQQQPGMTR [SEQ ID NO: 252]

TABLE-US-00261 PEPTIDE : SEEGYYGEQQQQPGMTR [SEQ ID NO: 253]

TABLE-US-00262 PEPTIDE : QGYYGEGSSEE [SEQ ID NO: 25 4]

TABLE-US-00263 PEPTIDE : YGGEGSSSEQGYYGEGSSEEGY [SE Q ID NO: 255]

TABLE-US-00264 PEPTIDE : YGEQQQQPGMTR [SEQ ID NO: 2 56]

TABLE-US-00265 PEPTIDE : YYGEQQQQPGMTR [SEQ ID NO: 257]

TABLE-US-00266 PEPTIDE : SYEESMPMPLEQGWSSSSSE [SEQ ID NO: 258]

TABLE-US-00267 PEPTIDE : YYGEGSSEEGYYGEQQQQPGMTR [S EQ ID NO: 259]

TABLE-US-00268 PEPTIDE : QQQQPGMTRV [SEQ ID NO: 260 ]

TABLE-US-00269 PEPTIDE : GEQQQQPGMTR [SEQ ID NO: 26 1]

TABLE-US-00270 PEPTIDE : SYEESMPMPLEQGWSSSSSEY [SEQ ID NO: 262]

TABLE-US-00271 PEPTIDE : YYGGEGSSSEQGYYGEGSSEEGY [S EQ ID NO: 263]

TABLE-US-00272 PEPTIDE : YGEQQQQPGMTRVR [SEQ ID NO: 264]

TABLE-US-00273 PEPTIDE : GEGSSEEGYYGEQQQQPGMTR [SEQ ID NO: 265]

TABLE-US-00274 PEPTIDE : YGEGSSEEGYYGEQQQQPGMTR [SE Q ID NO: 266]

TABLE-US-00275 PEPTIDE : QQQQPGMTRVR [SEQ ID NO: 26 7]

TABLE-US-00276 PEPTIDE : QYAAQLPSMCRVEPQQCSIFAAGQY [SEQ ID NO: 268]

[0428] PROTEIN : P0C1U8 - 5 - Staphylococcus aureus

TABLE-US-00277 MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQTQSSKQQTP KIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYIQVEAPTG TFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTA EQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMSNNAETQVNQNITVT GYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIG IHWGGVPNEFNGAVFINENVRNFLKQNIEDIHFANDDQPNNPDNPDNPNN PDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID NO: 1 4]

TABLE-US-00278 PEPTIDE : APTGTFIASGVVVGKD [SEQ ID N O: 413]

TABLE-US-00279 PEPTIDE : LAIVKFSPNEQNKHIGE [SEQ ID NO: 414]

TABLE-US-00280 PEPTIDE : RHQITDTTNGHYAPVTYIQVE [SEQ ID NO: 415]

TABLE-US-00281 PEPTIDE : GDLAIVKFSPNEQNKHIGE [SEQ I D NO: 416]

TABLE-US-00282 PEPTIDE : NPDNPDNPNNPDNPNNPD [SEQ ID NO: 417]

[0429] PROTEIN : P14614 - 4- RICE

TABLE-US-00283 MATIAFSRLSIYFCVLLLCHGSMAQLFGPNVNPWHNPRQGGFRECRFDRL QAFEPLRRVRSEAGVTEYFDEKNEQFQCTGTFVIRRVIEPQGLLVPRYSN TPGMVYIIQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKI HQFRQGDIVALPAGVAHWFYNEGDAPVVALYVFDLNNNANQLEPRQKEFL LAGNNNREQQMYGRSIEQHSGQNIFSGFNNELLSEALGVNALVAKRLQGQ NDQRGEIIRVKNGLKLLRPAFAQQQEQAQQQEQAQAQYQVQYSEEQQPST RCNGLDENFCTIKARLNIENPSHADTYNPRAGRITRLNSQKFPILNLVQL SATRVNLYQNAILSPFWNVNAHSLVYIVQGHARVQVVSNLGKTVFNGVLR PGQLLIIPQHYVVLKKAEHEGCQYISFKTNANSMVSHLAGKNSIFRAMPV DVIANAYRISREQARSLKNNRGEELGAFTPRYQQQTYPGFSNESENEALE [SEQ ID NO: 6]

TABLE-US-00284 PEPTIDE : TVFNGVLRPGQL [SEQ ID NO: 2 69]

TABLE-US-00285 PEPTIDE : TVFNGVLRPGQLL [SEQ ID NO: 270]

TABLE-US-00286 PEPTIDE : SGFNNELLSEALGVNALVAK [SEQ ID NO: 271]

TABLE-US-00287 PEPTIDE : NGVLRPGQL [SEQ ID NO: 272]

TABLE-US-00288 PEPTIDE : ALVAKRLQGQNDQRGEI [SEQ ID NO: 273]

TABLE-US-00289 PEPTIDE : VPRYSNTPGM [SEQ ID NO: 274 ]

TABLE-US-00290 PEPTIDE : PRYSNTPGMV [SEQ ID NO: 275 ]

TABLE-US-00291 PEPTIDE : YSNTPGMVY [SEQ ID NO: 276]

TABLE-US-00292 PEPTIDE : LVPRYSNTPGM [SEQ ID NO: 27 7]

TABLE-US-00293 PEPTIDE : FYNEGDAPVV [SEQ ID NO: 278 ]

TABLE-US-00294 PEPTIDE : FYNEGDAPVVAL [SEQ ID NO: 2 79]

TABLE-US-00295 PEPTIDE : FEPLRRVRSEAGVTE [SEQ ID NO : 280]

TABLE-US-00296 PEPTIDE : FYNEGDAPVVALY [SEQ ID NO: 281]

TABLE-US-00297 PEPTIDE : FYNEGDAPVVA [SEQ ID NO: 28 2]

[0430] PROTEIN : P09918 - 14 - Pisum sativum

TABLE-US-00298 MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTTVGGVIGQGFDILGSTV DNLTAFLGRSVSLQLISATKPDATGKGKLGKATFLEGIISSLPTLGAGQS AFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLDDIPNHGSIYFVCNS WIYNAKHHKIDRIFFANQTYLPSETPAPLVHYREEELNNLRGDGTGERKE WERIYDYDVYNDLGNPDSGENHARPVLGGSETYPYPRRGRTGRKPTRKDP NSESRSDYVYLPRDEAFGHLKSSDFLTYGLKAVSQNVVPALESVFFDLNF TPNEFDSFDEVHGLYEGGIKLPTNILSQISPLPVLKEIFRTDGENTLKYP PPKVIQVSRSGWMTDEEFAREMLAGVNPNVICCLQEFPPRSKLDSQIYGD HTSKISKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTSTK AYATRTILFLNNNQNLKPLAIELSLPHPQGDEHGAVSYVYQPALEGVESS IWLLAKAYVIVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSCLHPIYKL LYPHYRDTMNINSLARLSLVNDGGIIEKTFLWGRYSMEMSSKVYKNWVFT EQALPADLIKRGMAIEDPSSPCGVKLVVEDYPYAVDGLEIWAIIKTWVQD YVSLYYTSDEKLRQDSELQAWWKELVEVGHGDKKNEPWWPKMQTREDLIE VCSIVIWTASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEFEELV KSPQKAYLKTITPKFQTLIDLSVIEILSRHASDELYLGERDNPNWTSDKR ALEAFKKFGNKLAEIEKKLTQRNNDEKLRNRHGPVEMPYTLLYPSSKEGL TFRGIPNSISI [SEQ ID NO: 7]

TABLE-US-00299 PEPTIDE : HGPVEMPYTLLYPSSK [SEQ ID N O: 283]

[0431] PROTEIN : P02857 - 1- PEA

TABLE-US-00300 MAKLLALSLSFCFLLLGGCFALREQPQQNECQLERLDALEPDNRIESEGG LIETWNPNNKQFRCAGVALSRATLQRNALRRPYYSNAPQEIFIQQGNGYF GMVFPGCPETFEEPQESEQGEGRRYRDRHQKVNRFREGDIIAVPTGIVFW MYNDQDTPVIAVSLTDIRSSNNQLDQMPRRFYLAGNHEQEFLQYQHQQGG KQEQENEGNNIFSGFKRDYLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVK GGLSIISPPEKQARHQRGSRQEEDEDEEKQPRHQRGSRQEEEEDEDEERQ PRHQRRRGEEEEEDKKERGGSQKGKSRRQGDNGLEETVCTAKLRLNIGPS SSPDIYNPEAGRIKTVTSLDLPVLRWLKLSAEHGSLHKNAMFVPHYNLNA NSIIYALKGRARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSDR FSYVAFKTNDRAGIARLAGTSSVINNLPLDVVAATFNLQRNEARQLKSNN PFKFLVPARESENRASA [SEQ ID NO: 8]

TABLE-US-00301 PEPTIDE : LDALEPDNR [SEQ ID NO: 284]

TABLE-US-00302 PEPTIDE : DALEPDNR [SEQ ID NO: 285]

TABLE-US-00303 PEPTIDE : HGSLHKNAMFVPHYNLNANSIIYA [ SEQ ID NO: 286]

TABLE-US-00304 PEPTIDE : LAGTSSVINNLPLDVVAATF [SEQ ID NO: 287]

TABLE-US-00305 PEPTIDE : FREGDIIAVPTGIVFW [SEQ ID N O: 288]

TABLE-US-00306 PEPTIDE : GTSSVINNLPLDVVAATFNLQRNE [ SEQ ID NO: 289]

TABLE-US-00307 PEPTIDE : KGAIVKVKGGLSIISPPE [SEQ ID NO: 290]

TABLE-US-00308 PEPTIDE : RLAGTSSVINNLPLD [SEQ ID NO : 291]

TABLE-US-00309 PEPTIDE : AGTSSVINNLPLDVVAATFNLQRNE [SEQ ID NO: 292]

TABLE-US-00310 PEPTIDE : AGTSSVINNLPL [SEQ ID NO: 2 93]

TABLE-US-00311 PEPTIDE : LAGTSSVINNLPLDVVA [SEQ ID NO: 294]

TABLE-US-00312 PEPTIDE : AGTSSVINNLPLDV [SEQ ID NO: 295]

TABLE-US-00313 PEPTIDE : AGRIKTVTSLDLPVLRW [SEQ ID NO: 296]

TABLE-US-00314 PEPTIDE : AGRIKTVTSLDLPVLR [SEQ ID N O: 297]

TABLE-US-00315 PEPTIDE : FREGDIIAVPTGIVF [SEQ ID NO : 298]

TABLE-US-00316 PEPTIDE : AGTSSVINNLPLD [SEQ ID NO: 299]

TABLE-US-00317 PEPTIDE : LAGTSSVINNLPL [SEQ ID NO: 300]

TABLE-US-00318 PEPTIDE : LAGTSSVINNLPLDVV [SEQ ID N O: 301]

TABLE-US-00319 PEPTIDE : EGDIIAVPTGIVF [SEQ ID NO: 302]

TABLE-US-00320 PEPTIDE : LAGTSSVINNLPLDV [SEQ ID NO : 303]

TABLE-US-00321 PEPTIDE : AGRALTVPQNYAVAAKSLSD [SEQ ID NO: 304]

TABLE-US-00322 PEPTIDE : AGRALTVPQNYA [SEQ ID NO: 3 05]

TABLE-US-00323 PEPTIDE : LAGTSSVINNLPLD [SEQ ID NO: 306]

TABLE-US-00324 PEPTIDE : RAGIARLAGTSSVINNLPLDVVA [S EQ ID NO: 307]

[0432] PROTEIN : P02855 - 4 - PEA

TABLE-US-00325 DNAEIEKILLEEHEKETHHRRGLRDKRQQSQEKNVIVKVSKKQIEELSKN AKSSSKKSVSSRSEPFNLKSSDPIYSNQYGKFFEITPKKNPQLQDLDIFV NYVEIKEGSLWLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEDD EEEEQREEETKNQVQSYKAKLTPGDVFVIPAGHPVAVRASSNLNLLGFGI NAENNQRNFLAGEEDNVISQIQKQVKDLTFPGSAQEVDRLLENQKQSYFA NAQPQQRETRSQEIKEHLYSILGAF [SEQ IDNO: 9]

TABLE-US-00326 PEPTIDE : RASSNLNLLGFGINAE [SEQ ID N O: 308]

TABLE-US-00327 PEPTIDE : VTVNEGKGDFEL [SEQ ID NO: 3 09]

TABLE-US-00328 PEPTIDE : VRASSNLNLLGFGINAE [SEQ ID NO: 310]

TABLE-US-00329 PEPTIDE : VRASSNLNLLGFG [SEQ ID NO: 311]

TABLE-US-00330 PEPTIDE : HPVAVRASSNLNLLGFG [SEQ ID NO: 312]

TABLE-US-00331 PEPTIDE : TKNQVQSYKAKLTPGD [SEQ ID N O: 313]

TABLE-US-00332 PEPTIDE : HPVAVRASSNLNLLG [SEQ ID NO : 314]

TABLE-US-00333 PEPTIDE : KAKLTPGDVFVIPAG [SEQ ID NO : 315]

TABLE-US-00334 PEPTIDE : DLTFPGSAQEVDRLLENQK [SEQ I D NO: 316]

TABLE-US-00335 PEPTIDE : PAGHPVAVR [SEQ ID NO: 317]

TABLE-US-00336 PEPTIDE : AKLTPGDVFVIPAGHPVA [SEQ ID NO: 318]

TABLE-US-00337 PEPTIDE : SYKAKLTPGDVFVIPAGHPVA [SEQ ID NO: 319]

TABLE-US-00338 PEPTIDE : LTPGDVFVIPAGHPVAVR [SEQ ID NO: 320]

TABLE-US-00339 PEPTIDE : VQSYKAKLTPGDVFVIPAG [SEQ I D NO: 321]

TABLE-US-00340 PEPTIDE : YKAKLTPGDVFVIPAGHPVA [SEQ ID NO: 322]

TABLE-US-00341 PEPTIDE : FVIPAGHPVAVR [SEQ ID NO: 3 23]

TABLE-US-00342 PEPTIDE : YKAKLTPGDVFVIPAG [SEQ ID N O: 324]

TABLE-US-00343 PEPTIDE : DLTFPGSAQEVDR [SEQ ID NO: 325]

TABLE-US-00344 PEPTIDE : AKLTPGDVFVIPAGHPVAVR [SEQ ID NO: 326]

TABLE-US-00345 PEPTIDE : LTPGDVFVIPAG [SEQ ID NO: 3 27]

TABLE-US-00346 PEPTIDE : SYKAKLTPGDVFVIPAG [SEQ ID NO: 328]

TABLE-US-00347 PEPTIDE : SYKAKLTPGDVFVIPAGHPVAVR [S EQ ID NO: 329]

TABLE-US-00348 PEPTIDE : VIPAGHPVAVR [SEQ ID NO: 33 0]

TABLE-US-00349 PEPTIDE : QVQSYKAKLTPGDVFVIPAG [SEQ ID NO: 331]

TABLE-US-00350 PEPTIDE : AKLTPGDVFVIPAG [SEQ ID NO: 332]

TABLE-US-00351 PEPTIDE : HPVAVRASSNLNLLGFGINAE [SEQ ID NO: 333]

TABLE-US-00352 PEPTIDE : YKAKLTPGDVFVIPAGHPVAVR [SE Q ID NO: 334]

TABLE-US-00353 PEPTIDE : TKNQVQSYKAKLTPGDVFVIPAG [S EQ ID NO: 335]

TABLE-US-00354 PEPTIDE : PFNLKSSDPIYS [SEQ ID NO: 3 36]

TABLE-US-00355 PEPTIDE : IEKILLEE [SEQ ID NO: 337]

TABLE-US-00356 PEPTIDE : SRSEPFNLKSSDPIYS [SEQ ID N O: 338]

TABLE-US-00357 PEPTIDE : HPVAVRASSNLNL [SEQ ID NO: 339]

[0433] PROTEIN : D3VNE1 - 5 - PEA

TABLE-US-00358 MAATPIKPLMLLAIAFLASVCVSSRSDQENPFIFKSNRFQTLYENENGHI RLLQKFDKRSKIFENLQNYRLLEYKSKPRTLFLPQYTDADFILVVLSGKA TLTVLKSNDRNSFNLERGDTIKLPAGTIAYLANRDDNEDLRVLDLTIPVN KPGQLQSFLLSGTQNQPSLLSGFSKNILEAAFNTNYEEIEKVLLEQQEQE PQHRRSLKDRRQEINEENVIVKVSREQIEELSKNAKSSSKKSVSSESGPF NLRSRNPIYSNKFGKFFEITPEKNQQLQDLDIFVNSVDIKEGSLLLPNYN SRAIVIVTVTEGKGDFELVGQRNENQGKENDKEEEQEEETSKQVQLYRAK LSPGDVFVIPAGHPVAINASSDLNLIGFGINAENNERNFLAGEEDNVISQ VERPVKELAFPGSSHEVDRLLKNQKQSYFANAQPLQRE [SEQ ID NO: 10]

TABLE-US-00359 PEPTIDE : TLFLPQYTDADFILVVLSGK [SEQ ID NO: 340]

[0434] PROTEIN : P07728 - 1- RICE

TABLE-US-00360 MASINRPIVFFTVCLFLLCNGSLAQQLLGQSTSQWQSSRRGSPRECRFDR LQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSVVRRVIEPRGLLLPHYT NGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLTESQSQSQKFKD EHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVTDLNNGANQLDPR QRDFLLAGNKRNPQAYRREVEERSQNIFSGFSTELLSEALGVSSQVARQL QCQNDQRGEIVRVEHGLSLLQPYASLQEQEQGQVQSRERYQEGQYQQSQY GSGCSNGLDETFCTLRVRQNIDNPNRADTYNPRAGRVTNLNTQNFPILSL VQMSAVKVNLYQNALLSPFWNINAHSVVYITQGRARVQVVNNNGKTVFNG ELRRGQLLIIPQHYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRA LPNDVLANAYRISREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNAAESS [SEQ ID NO: 11]

TABLE-US-00361 PEPTIDE : EVEERSQNIF [SEQ ID NO: 341 ]

TABLE-US-00362 PEPTIDE : VEERSQNIFSGF [SEQ ID NO: 3 42]

TABLE-US-00363 PEPTIDE : ASLQEQEQGQVQ [SEQ ID NO: 3 43]

TABLE-US-00364 PEPTIDE : QEQEQGQVQSR [SEQ ID NO: 34 4]

TABLE-US-00365 PEPTIDE : ASLQEQEQGQVQSR [SEQ ID NO: 345]

TABLE-US-00366 PEPTIDE : EVEERSQNIFSGF [SEQ ID NO: 346]

TABLE-US-00367 PEPTIDE : VTDLNNGANQLDPRQRD [SEQ ID NO: 347]

TABLE-US-00368 PEPTIDE : VEHGLSLLQPYASL [SEQ ID NO: 348]

TABLE-US-00369 PEPTIDE : IYVTDLNNGANQLDPRQRDFL [SEQ ID NO: 349]

TABLE-US-00370 PEPTIDE : VTDLNNGANQLDPRQRDFL [SEQ I D NO: 350]

TABLE-US-00371 PEPTIDE : VEHGLSLLQPYASLQEQEQGQVQSR [SEQ ID NO: 351]

TABLE-US-00372 PEPTIDE : VTDLNNGANQLDPR [SEQ ID NO: 352]

TABLE-US-00373 PEPTIDE : IYVTDLNNGANQLDPRQRD [SEQ I D NO: 353]

TABLE-US-00374 PEPTIDE : YVTDLNNGANQLDPRQRDFL [SEQ ID NO: 354]

TABLE-US-00375 PEPTIDE : YVTDLNNGANQLDPR [SEQ ID NO : 355]

TABLE-US-00376 PEPTIDE : STELLSEALGVSSQVAR [SEQ ID NO: 356]

TABLE-US-00377 PEPTIDE : HGLSLLQPYASLQEQE [SEQ ID N O: 357]

TABLE-US-00378 PEPTIDE : SGFSTELLSEALGVSSQVAR [SEQ ID NO: 358]

[0435] PROTEIN : P07730 - 2 - RICE

TABLE-US-00379 MASINRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDR LQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGLLLPHYT NGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAQLTESQSQSHKFKD EHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVTDINNGANQLDPR QRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQL QCQNDQRGEIVRVERGLSLLQPYASLQEQEQGQMQSREHYQEGGYQQSQY GSGCPNGLDETFCTMRVRQNIDNPNRADTYNPRAGRVTNLNSQNFPILNL VQMSAVKVNLYQNALLSPFWNINAHSIVYITQGRAQVQVVNNNGKTVFNG ELRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRA LPTDVLANAYRISREEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [SEQ ID NO: 12]

TABLE-US-00380 PEPTIDE : GAFTPLQYKSYQD [SEQ ID NO: 359]

TABLE-US-00381 PEPTIDE : GLLLPHYTNGASLVY [SEQ ID NO : 360]

TABLE-US-00382 PEPTIDE : FLLAGNKRNPQAYRRE [SEQ ID N O: 361]

TABLE-US-00383 PEPTIDE : ALPTDVLANAYR [SEQ ID NO: 3 62]

TABLE-US-00384 PEPTIDE : DFLLAGNK [SEQ ID NO: 363]

TABLE-US-00385 PEPTIDE : DVLANAYR [SEQ ID NO: 364]

TABLE-US-00386 PEPTIDE : GAFTPLQYK [SEQ ID NO: 365]

TABLE-US-00387 PEPTIDE : QGDVIALPAGVAHW [SEQ ID NO: 366]

TABLE-US-00388 PEPTIDE : FGAFTPLQYKSY [SEQ ID NO: 3 67]

TABLE-US-00389 PEPTIDE : FLLAGNKRNPQAYR [SEQ ID NO: 368]

TABLE-US-00390 PEPTIDE : FGAFTPLQYKSYQ [SEQ ID NO: 369]

TABLE-US-00391 PEPTIDE : GLSLLQPYASLQEQE [SEQ ID NO : 370]

TABLE-US-00392 PEPTIDE : AFTPLQYK [SEQ ID NO: 371]

TABLE-US-00393 PEPTIDE : FGAFTPLQYKSYQD [SEQ ID NO: 372]

TABLE-US-00394 PEPTIDE : GDEFGAFTPLQYK [SEQ ID NO: 373]

TABLE-US-00395 PEPTIDE : FGAFTPLQYKSYQDV [SEQ ID NO : 374]

TABLE-US-00396 PEPTIDE : FGAFTPLQYK [SEQ ID NO: 375 ]

TABLE-US-00397 PEPTIDE : FGAFTPLQYKS [SEQ ID NO: 37 6]

TABLE-US-00398 PEPTIDE : VYIIQGRGITGPTF [SEQ ID NO: 377]

TABLE-US-00399 PEPTIDE : YIIQGRGITGPTF [SEQ ID NO: 378]

TABLE-US-00400 PEPTIDE : KTNPNSMVSHIAGK [SEQ ID NO: 379]

TABLE-US-00401 PEPTIDE : TNPNSMVSHIAGK [SEQ ID NO: 380]

TABLE-US-00402 PEPTIDE : PNSMVSHIAGKS [SEQ ID NO: 3 81]

TABLE-US-00403 PEPTIDE : NIDNPNRADTYNPRAGRVTN [SEQ ID NO: 382]

TABLE-US-00404 PEPTIDE : QRDFLLAGNKR [SEQ ID NO: 38 3]

TABLE-US-00405 PEPTIDE : LLQPYASLQEQE [SEQ ID NO: 3 84]

TABLE-US-00406 PEPTIDE : QRDFLLAGNK [SEQ ID NO: 385 ]

TABLE-US-00407 PEPTIDE : QEQEQGQMQSR [SEQ ID NO: 38 6]

TABLE-US-00408 PEPTIDE : SLLQPYASLQEQE [SEQ ID NO: 387]

TABLE-US-00409 PEPTIDE : ASLQEQEQGQM [SEQ ID NO: 38 8]

TABLE-US-00410 PEPTIDE : ASLQEQEQGQMQSR [SEQ ID NO: 389]

TABLE-US-00411 PEPTIDE : DFLLAGNKR [SEQ ID NO: 390]

TABLE-US-00412 PEPTIDE : QAFEPIRSVRSQAGTTEF [SEQ ID NO: 391]

TABLE-US-00413 PEPTIDE : KTNPNSMVSHIAGKSSIF [SEQ ID NO: 392]

TABLE-US-00414 PEPTIDE : VRRVIEPRGLLLPHYTNGASL [SEQ ID NO: 393]

TABLE-US-00415 PEPTIDE : FGAFTPLQYKSYQDVYN [SEQ ID NO: 394]

TABLE-US-00416 PEPTIDE : IALPAGVAHW [SEQ ID NO: 395 ]

TABLE-US-00417 PEPTIDE : RVRQNIDNPNRADTYNPRAGRVTNL [SEQ ID NO: 396]

TABLE-US-00418 PEPTIDE : NIDNPNRADTYNPRAGRVTNL [SEQ ID NO: 397]

TABLE-US-00419 PEPTIDE : GAFTPLQYKSYQDVYN [SEQ ID N O: 398]

TABLE-US-00420 PEPTIDE : PNSMVSHIAGKSSIFR [SEQ ID N O: 399]

TABLE-US-00421 PEPTIDE : RLQAFEPIRSVRSQAGTTE [SEQ I D NO: 400]

TABLE-US-00422 PEPTIDE : TNPNSMVSHIAGKSSIFR [SEQ ID NO: 401]

[0436] PROTEIN : Q0D750 - 3 - RICE

TABLE-US-00423 MASNKVVFSVLLLAVVSVLAATATMAEYHHQDQVVYTPGPLCQPGMGYPM YPLPRCRALVKRQCVGRGTAAAAEQVRRDCCRQLAAVDDSWCRCEAISHM LGGIYRELGAPDVGHPMSEVFRGCRRGDLERAAASLPAFCNVDIPNGGGG VCYWLARSGY [SEQ ID NO: 13]

TABLE-US-00424 PEPTIDE : ELGAPDVGHPM [SEQ ID NO: 40 2]

TABLE-US-00425 PEPTIDE : LGAPDVGHPM [SEQ ID NO: 403 ]

TABLE-US-00426 PEPTIDE : ELGAPDVGHPMSEVF [SEQ ID NO : 404]

TABLE-US-00427 PEPTIDE : ELGAPDVGHPMS [SEQ ID NO: 4 05]

TABLE-US-00428 PEPTIDE : ELGAPDVGHPMSEVFR [SEQ ID N O: 406]

TABLE-US-00429 PEPTIDE : ELGAPDVGHPMSEV [SEQ ID NO: 407]

TABLE-US-00430 PEPTIDE : ELGAPDVGHPMSE [SEQ ID NO: 408]

TABLE-US-00431 PEPTIDE : LGAPDVGHPMSE [SEQ ID NO: 4 09]

TABLE-US-00432 PEPTIDE : YRELGAPDVGHPMSE [SEQ ID NO : 410]

TABLE-US-00433 PEPTIDE : LGAPDVGHPMSEV [SEQ ID NO: 411]

TABLE-US-00434 PEPTIDE : RELGAPDVGHPMSE [SEQ ID NO: 412]

Additional Peptides (and Source Protein)

[0437] TABLE-US-00435 HPRPPKPDAPR [SEQ ID NO: 452] - Q0D9DO

TABLE-US-00436 LQQAPPPPQR [SEQ ID NO: 453] - Q6AVS5

TABLE-US-00437 VGWGEQPWSPY [SEQ ID NO: 454] - Q8H920

TABLE-US-00438 FHMPP [SEQ ID NO: 455] - O49927

TABLE-US-00439 FRRP [SEQ ID NO: 456] - P29835

TABLE-US-00440 FWM [SEQ ID NO: 457] - P15838

TABLE-US-00441 HMPPS [SEQ ID NO: 458] - 049927

TABLE-US-00442 PVEMPTLLYPS [SEQ ID NO: 459]

TABLE-US-00443 HMPSS [SEQ ID NO: 460] - O49927

TABLE-US-00444 HRFR [SEQ ID NO: 461] - Q712V4

TABLE-US-00445 HRRS [SEQ ID NO: 462] - P13918

TABLE-US-00446 HSPR [SEQ ID NO: 463] - P14323

TABLE-US-00447 HWF [SEQ ID NO: 464] - P14323

TABLE-US-00448 MFRR [SEQ ID NO: 465] - Q41000

TABLE-US-00449 MFRRP [SEQ ID NO: 466] - P29835

TABLE-US-00450 MPPS [SEQ ID NO: 467] - 049927

TABLE-US-00451 MPRR [SEQ ID NO: 468] - P15838

TABLE-US-00452 NMPS [SEQ ID NO: 469] - P20698

TABLE-US-00453 PHMP [SEQ ID NO: 470] - O49927

TABLE-US-00454 PHMPS [SEQ ID NO: 471] - O49927

TABLE-US-00455 PRRF [SEQ ID NO: 472] - P15838

TABLE-US-00456 WMK [SEQ ID NO: 473] - O04434

TABLE-US-00457 DSINALEPDHR [SEQ ID NO: 474] - P05692

TABLE-US-00458 ELTFPGSVQ [SEQ ID NO: 475] - Q9M3X6

TABLE-US-00459 ELTFPGSVQE [SEQ ID NO: 476] - Q9M3X6

TABLE-US-00460 IFEDAITIPGR [SEQ ID NO: 477] - P09886

TABLE-US-00461 LDALEPDNRIESE [SEQ ID NO: 478] - P02857

TABLE-US-00462 KTLDYWPSLR [SEQ ID NO: 479] - P08688

TABLE-US-00463 RHGEWGPSY [SEQ ID NO: 480]

TABLE-US-00464 ILVDGSHDIER [SEQ ID NO: 481] - Q5N725

TABLE-US-00465 LVSHPIAAHEGR [SEQ ID NO: 482] - P14614

TABLE-US-00466 NLAQAPAQALL [SEQ ID NO: 483] -QODJ38

TABLE-US-00467 FLPQHTD [SEQ ID NO: 484] - P13918

TABLE-US-00468 LEPDNR [SEQ ID NO: 485] - P15838

TABLE-US-00469 LQSQND [SEQ ID NO: 486] - P14323

TABLE-US-00470 LQSQNDQRGEI [SEQ ID NO: 487] - P14323

TABLE-US-00471 QSQNDQRGEIIHVK [SEQ ID NO: 488] - P14323

TABLE-US-00472 RGEIIHVK [SEQ ID NO: 489] - P14323

TABLE-US-00473 RLQSQNDQ [SEQ ID NO: 490] - P14323

TABLE-US-00474 RLQSQNDQRG [SEQ ID NO: 491] - P14323

TABLE-US-00475 RLQSQNDQRGEIIH [SEQ ID NO: 492] - P14323

TABLE-US-00476 VFDGVLRPG [SEQ ID NO: 493] - P14323

TABLE-US-00477 HNPR [SEQ ID NO: 494] - P14614

TABLE-US-00478 HPMS [SEQ ID NO: 495] - Q0D750

TABLE-US-00479 HPSF [SEQ ID NO: 496] - Q0DEV5

TABLE-US-00480 MPMP [SEQ ID NO: 497] - P29835

TABLE-US-00481 PMPL [SEQ ID NO: 498] - P29835

TABLE-US-00482 PNSM [SEQ ID NO: 499] - P07728

TABLE-US-00483 WDP [SEQ ID NO: 500] - B5A8N6

TABLE-US-00484 LRGFSK [SEQ ID NO: 501] - Q9M3X6

TABLE-US-00485 RSQNIF [SEQ ID NO: 502] - P07728

TABLE-US-00486 YLRGFS [SEQ ID NO: 503] - Q9M3X6

TABLE-US-00487 GALMLPHYN [SEQ ID NO: 504] - Q9M3X6

TABLE-US-00488 GALMLPHYNSR [SEQ ID NO: 505] -Q9M3X6

TABLE-US-00489 KNPQLQDLDIFVNYVEIK [SEQ ID NO: 700] P02855

TABLE-US-00490 PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 701] P13918

TABLE-US-00491 RGPQQYAEWQINEK [SEQ ID NO: 702] Q6K7K6

TABLE-US-00492 VLDLAIPVNRPGQL [SEQ ID NO: 703] Q6K508

TABLE-US-00493 GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID NO: 704] P09918

TABLE-US-00494 LDVTPLSLGL [SEQ ID NO: 717]

TABLE-US-00495 EEGIQLVAEAIR [SEQ ID NO: 718]

TABLE-US-00496 YSLKPLVPR [SEQ ID NO: 719]

TABLE-US-00497 WHT [SEQ ID NO: 720]

TABLE-US-00498 WHN [SEQ ID NO: 721]

TABLE-US-00499 NNPF [SEQ ID NO: 722]

TABLE-US-00500 MRFR [SEQ ID NO: 723]

TABLE-US-00501 MPPSS [SEQ ID NO: 724]

TABLE-US-00502 HMPS [SEQ ID NO: 725]

TABLE-US-00503 HMPPS [SEQ ID NO: 726]

TABLE-US-00504 GHPM [SEQ ID NO: 727]

TABLE-US-00505 FWN [SEQ ID NO: 728]

TABLE-US-00506 FHMP [SEQ ID NO: 729]

TABLE-US-00507 WTIVQGLPIDE [SEQ ID NO: 730]

TABLE-US-00508 GYPMYPLPR [SEQ ID NO: 731]

TABLE-US-00509 HGGEGGRPY [SEQ ID NO: 732]

TABLE-US-00510 LRGFSK [SEQ ID NO: 733]

TABLE-US-00511 GALMLPHYN [SEQ ID NO: 734]

TABLE-US-00512 GALMLPHYNSR [SEQ ID NO: 735]

TABLE-US-00513 VFDGVLRPG [SEQ ID NO: 736]

TABLE-US-00514 LQSQND [SEQ ID NO: 737]

TABLE-US-00515 LQSQNDQRGEI [SEQ ID NO: 738]

TABLE-US-00516 QSQNDQRGEIIHVK [SEQ ID NO: 739]

TABLE-US-00517 RGEIIHVK [SEQ ID NO: 740]

TABLE-US-00518 RLQSQNDQ [SEQ ID NO: 741]

TABLE-US-00519 RLQSQNDQRG [SEQ ID NO: 742]

TABLE-US-00520 RLQSQNDQRGEIIH [SEQ ID NO: 743]

TABLE-US-00521 MPMP [SEQ ID NO: 744]

TABLE-US-00522 PMPL [SEQ ID NO: 745]

TABLE-US-00523 LEPDNR [SEQ ID NO: 746]

TABLE-US-00524 GIARLAGTSSVIN [SEQ ID NO: 747]

TABLE-US-00525 RSQNIF [SEQ ID NO: 748]

TABLE-US-00526 PNSM [SEQ ID NO: 749]

TABLE-US-00527 GHPM [SEQ ID NO: 750]

TABLE-US-00528 HPMS [SEQ ID NO: 751]

TABLE-US-00529 FLPQHTD [SEQ ID NO: 752]

TABLE-US-00530 EWQINEK [SEQ ID NO: 753]

TABLE-US-00531 GPQQYAEWQINEK [SEQ ID NO: 754]

TABLE-US-00532 PQQYAEWQ [SEQ ID NO: 755]

TABLE-US-00533 RGPQQYA [SEQ ID NO: 756]

TABLE-US-00534 HNPR [SEQ ID NO: 757]

TABLE-US-00535 WHN [SEQ ID NO: 758]

TABLE-US-00536 WDP [SEQ ID NO: 759]

TABLE-US-00537 HPSF [SEQ ID NO: 760]

TABLE-US-00538 PGQLQSFLLSGNQNQQNYLSGF [SEQ ID NO: 761]

TABLE-US-00539 QLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 762]

TABLE-US-00540 QSFLLSGNQNQQ [SEQ ID NO: 763]

TABLE-US-00541 PGQLQSFLLSGN [SEQ ID NO: 764]

TABLE-US-00542 QSFLLSGNQ [SEQ ID NO: 765]

TABLE-US-00543 QNQQNYLSGFSK [SEQ ID NO: 766]

TABLE-US-00544 YLRGFS [SEQ ID NO: 767]

TABLE-US-00545 PVEMPTLLYPS [SEQ ID NO: 768]

TABLE-US-00546 RGPQQYAEWQINE [SEQ ID NO: 769]

TABLE-US-00547 GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID NO: 770]

TABLE-US-00548 KNPQLQDLDIFVNYVEIK [SEQ ID NO: 771]

TABLE-US-00549 PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 772]

TABLE-US-00550 RGPQQYAEWQINEK [SEQ ID NO: 773]

TABLE-US-00551 VLDLAIPVNRPGQL [SEQ ID NO: 774]

TABLE-US-00552 RGPQQYAEWQINEK [SEQ ID NO: 775]

[0438] PROTEIN P02855 [SEQ ID NOs: 546-552]

TABLE-US-00553 PEPTIDE : SRAIVIVTVNE [SEQ ID NO: 546]

TABLE-US-00554 PEPTIDE : AKLTPGDV [SEQ ID NO: 547]

TABLE-US-00555 PEPTIDE : IVIVTVNEGK [SEQ ID NO:548]

TABLE-US-00556 PEPTIDE : LDALEPDNRIESEGGL [SEQ ID NO: 549] ( also in P02857)

TABLE-US-00557 PEPTIDE : RPYYSNAPQE [SEQ ID NO: 550] (also i n P02857)

TABLE-US-00558 PEPTIDE : LDALEPDNRIESEGGLIETWNPNNK [SEQ ID N O: 551] (also in P02857)

TABLE-US-00559 PEPTIDE : AIVIVTVNEGK [SEQ ID NO: 552] (also in P13918)

[0439] PROTEIN P02857 [SEQ ID NOs: 553-565]

TABLE-US-00560 PEPTIDE : LQVVNCNGNTVFDGEL [SEQ ID NO:553]

TABLE-US-00561 PEPTIDE : QVVNCNGNTVFDGEL [SEQ ID NO: 554]

TABLE-US-00562 PEPTIDE : IIAVPTGIVF [SEQ ID NO: 555]

TABLE-US-00563 PEPTIDE : GRRYRDRHQKVNRFRE [SEQ ID NO: 556]

TABLE-US-00564 PEPTIDE : RPYYSNAPQEI [SEQ ID NO: 557]

TABLE-US-00565 PEPTIDE : RLDALEPDNRIE [SEQ ID NO: 558]

TABLE-US-00566 PEPTIDE : RLDALEPDNRIESE [SEQ ID NO: 559]

TABLE-US-00567 PEPTIDE : LDALEPDNRIESEGGLIETW [SEQ ID NO: 56 0]

TABLE-US-00568 PEPTIDE : LDALEPDNRIE [SEQ ID NO: 561]

TABLE-US-00569 PEPTIDE : LDALEPDNRIESEGGLIE [SEQ ID NO: 562]

TABLE-US-00570 PEPTIDE : LDALEPDNRIESEGGL (also in P02855) [ SEQ ID NO: 563]

TABLE-US-00571 PEPTIDE : RPYYSNAPQE (also in P02857) [SEQ ID NO: 564]

TABLE-US-00572 PEPTIDE : LDALEPDNRIESEGGLIETWNPNNK (also in P02855) [SEQ ID NO: 565]

[0440] PROTEIN P07728 [SEQ ID NOs: 566-609]

TABLE-US-00573 PEPTIDE : VEHGLSLLQPYASLQEQEQGQVQSRER [SEQ ID NO: 566]

TABLE-US-00574 PEPTIDE : RSQNIFSGF [SEQ ID NO: 567]

TABLE-US-00575 PEPTIDE : GITGPTFPGCPESY [SEQ ID NO: 568]

TABLE-US-00576 PEPTIDE : CNGS [SEQ ID NO: 569]

TABLE-US-00577 PEPTIDE : SPREC [SEQ ID NO: 570]

TABLE-US-00578 PEPTIDE : PREC [SEQ ID NO: 571]

TABLE-US-00579 PEPTIDE : PRECR [SEQ ID NO: 572]

TABLE-US-00580 PEPTIDE : CPES [SEQ ID NO: 573]

TABLE-US-00581 PEPTIDE : SGCS [SEQ ID NO: 574]

TABLE-US-00582 PEPTIDE : CSNG [SEQ ID NO: 575]

TABLE-US-00583 PEPTIDE : RSQNIFSGFSTE [SEQ ID NO: 576]

TABLE-US-00584 PEPTIDE : VEEWSQNIFSGFST [SEQ ID NO: 577]

TABLE-US-00585 PEPTIDE : WSQNIFSGFSTEL [SEQ ID NO: 578]

TABLE-US-00586 PEPTIDE : WSQNIFSGFSTE [SEQ ID NO: 579]

TABLE-US-00587 PEPTIDE : STSQWQSSRR [SEQ ID NO: 580]

TABLE-US-00588 PEPTIDE : NRPI [SEQ ID NO: 581]

TABLE-US-00589 PEPTIDE : CDGS [SEQ ID NO: 582]

TABLE-US-00590 PEPTIDE : PRGC [SEQ ID NO: 583]

TABLE-US-00591 PEPTIDE : PRGCR [SEQ ID NO: 584]

TABLE-US-00592 PEPTIDE : RGCR [SEQ ID NO: 585]

TABLE-US-00593 PEPTIDE : GCRF [SEQ ID NO: 586]

TABLE-US-00594 PEPTIDE : PTFP [SEQ ID NO: 587]

TABLE-US-00595 PEPTIDE : PGCPE [SEQ ID NO: 588]

TABLE-US-00596 PEPTIDE : GCPE [SEQ ID NO: 589]

TABLE-US-00597 PEPTIDE : CPET [SEQ ID NO: 590]

TABLE-US-00598 PEPTIDE : AHWC [SEQ ID NO: 591]

TABLE-US-00599 PEPTIDE : HWCY [SEQ ID NO: 592]

TABLE-US-00600 PEPTIDE : SGCP [SEQ ID NO: 593]

TABLE-US-00601 PEPTIDE : SGCPN [SEQ ID NO: 594]

TABLE-US-00602 PEPTIDE : GCPN [SEQ ID NO: 595]

TABLE-US-00603 PEPTIDE : CPNG [SEQ ID NO: 596]

TABLE-US-00604 PEPTIDE : TFCTM [SEQ ID NO: 597]

TABLE-US-00605 PEPTIDE : FCTM [SEQ ID NO: 598]

TABLE-US-00606 PEPTIDE : FCTMR [SEQ ID NO: 599]

TABLE-US-00607 PEPTIDE : CTMR [SEQ ID NO: 600]

TABLE-US-00608 PEPTIDE : EGCA [SEQ ID NO: 601]

TABLE-US-00609 PEPTIDE : SQNIFSGFSTELL [SEQ ID NO: 602]

TABLE-US-00610 PEPTIDE : SQNIFSGFSTE [SEQ ID NO: 603]

TABLE-US-00611 PEPTIDE : QNDQRGEIVR [SEQ ID NO: 604]

TABLE-US-00612 PEPTIDE : SQNIFSGFSTEL [SEQ ID NO: 605] (also in P07730)

TABLE-US-00613 PEPTIDE : QLQCQNDQRGEI [SEQ ID NO: 606] (also in P07730)

TABLE-US-00614 PEPTIDE : LGQSTSQWQSSR [SEQ ID NO: 607] (also in P07730)

TABLE-US-00615 PEPTIDE : QQLLGQSTSQWQSSR [SEQ ID NO: 608] (a lso in P07730)

TABLE-US-00616 PEPTIDE : LLGQSTSQWQSSR [SEQ ID NO: 609] (als o in P07730)

[0441] PROTEIN P07730 [SEQ ID NOs: 610-619]

TABLE-US-00617 PEPTIDE : NDQRGEIVR [SEQ ID NO: 610]

TABLE-US-00618 PEPTIDE : GQSTSQWQSSR [SEQ ID NO: 611]

TABLE-US-00619 PEPTIDE : STSQWQSSR [SEQ ID NO: 612]

TABLE-US-00620 PEPTIDE : GITGPTFPGCPET [SEQ ID NO: 613]

TABLE-US-00621 PEPTIDE : GITGPTFPGCPETY [SEQ ID NO: 614]

TABLE-US-00622 PEPTIDE : SQNIFSGFSTEL [SEQ ID NO: 615] (also in P07728)

TABLE-US-00623 PEPTIDE : QLQCQNDQRGEI [SEQ ID NO: 616] (also in P07728)

TABLE-US-00624 PEPTIDE : LGQSTSQWQSSR [SEQ ID NO: 617] (also in P07728)

TABLE-US-00625 PEPTIDE : QQLLGQSTSQWQSSR [SEQ ID NO: 618] (a lso in P07728)

TABLE-US-00626 PEPTIDE : LLGQSTSQWQSSR [SEQ ID NO: 619] (als o in P07728)

[0442] PROTEIN P09918 [SEQ ID NOs: 620-630]

TABLE-US-00627 PEPTIDE : IFFANQTYL [SEQ ID NO: 620]

TABLE-US-00628 PEPTIDE : EHLEPNLEGLTVEE [SEQ ID NO: 621]

TABLE-US-00629 PEPTIDE : IFFANQTYLPSETPAPLVHYREEELNNLRGDGTGE R [SEQ ID NO: 622]

TABLE-US-00630 PEPTIDE : IHFEWDDDMGIPGAFYIK [SEQ ID NO: 623]

TABLE-US-00631 PEPTIDE : IFFANQTYLPSETPAPLVHYREEELNNLR [SEQ ID NO: 624]

TABLE-US-00632 PEPTIDE : TEQALPADLIK [SEQ ID NO: 625]

TABLE-US-00633 PEPTIDE : EHLEPNLEGLTVEEAIQNKK [SEQ ID NO: 62 6]

TABLE-US-00634 PEPTIDE : ISKEHLEPNLEGLTVEEAIQNKK [SEQ ID NO: 627]

TABLE-US-00635 PEPTIDE : LSLPHPQGDEHGAVSY [SEQ ID NO: 628]

TABLE-US-00636 PEPTIDE : ISKEHLEPNLEGLTVEEAIQNK [SEQ ID NO: 629]

TABLE-US-00637 PEPTIDE : EHLEPNLEGLTVEEAIQNK [SEQ ID NO: 630 ]

[0443] PROTEIN POC1U8 [SEQ ID NO: 631]

TABLE-US-00638 PEPTIDE : LSTTGGNSGSPVFNEKNE [SEQ ID NO: 631]

[0444] PROTEIN P13918 [SEQ ID NOs: 632-639]

TABLE-US-00639 PEPTIDE : QSFLLSGNQNQQNYLSG [SEQ ID NO: 632]

TABLE-US-00640 PEPTIDE : VLDLAIPVNRPGQLQS [SEQ ID NO: 633]

TABLE-US-00641 PEPTIDE : VLDLAIPVNRPGQLQSFL [SEQ ID NO: 634]

TABLE-US-00642 PEPTIDE : FLLSGNQNQQNYLSG [SEQ ID NO: 635]

TABLE-US-00643 PEPTIDE : FLLSGNQNQQNYLSGFSK [SEQ ID NO: 636]

TABLE-US-00644 PEPTIDE : DPQNPFIFKSNKFQTLFE [SEQ ID NO: 637]

TABLE-US-00645 PEPTIDE : ELAFPGSAQEVDRILENQK [SEQ ID NO: 638 ]

TABLE-US-00646 PEPTIDE : AIVIVTVNEGK (also in P02855) [SEQ I D NO: 639]

[0445] PROTEIN P14323 [SEQ ID NOs: 640-667]

TABLE-US-00647 PEPTIDE : INAVAAKRLQSQNDQRGE [SEQ ID NO: 640]

TABLE-US-00648 PEPTIDE : NRAQQQQVYGSSIE [SEQ ID NO: 641]

TABLE-US-00649 PEPTIDE : PSTNPWHSPR [SEQ ID NO: 642]

TABLE-US-00650 PEPTIDE : CHGS [SEQ ID NO: 643]

TABLE-US-00651 PEPTIDE : CHGSM [SEQ ID NO: 644]

TABLE-US-00652 PEPTIDE : PWHS [SEQ ID NO: 645]

TABLE-US-00653 PEPTIDE : FREC [SEQ ID NO: 646]

TABLE-US-00654 PEPTIDE : RECR [SEQ ID NO: 647]

TABLE-US-00655 PEPTIDE : ECRF [SEQ ID NO: 648]

TABLE-US-00656 PEPTIDE : CRFD [SEQ ID NO: 649]

TABLE-US-00657 PEPTIDE : CRFDR [SEQ ID NO: 650]

TABLE-US-00658 PEPTIDE : CTGT [SEQ ID NO: 651]

TABLE-US-00659 PEPTIDE : FPGC [SEQ ID NO: 652]

TABLE-US-00660 PEPTIDE : FPGCP [SEQ ID NO: 653]

TABLE-US-00661 PEPTIDE : PGCP [SEQ ID NO: 654]

TABLE-US-00662 PEPTIDE : PGCPA [SEQ ID NO: 655]

TABLE-US-00663 PEPTIDE : PGCPAT [SEQ ID NO: 656]

TABLE-US-00664 PEPTIDE : GCPA [SEQ ID NO: 657]

TABLE-US-00665 PEPTIDE : CPAT [SEQ ID NO: 658]

TABLE-US-00666 PEPTIDE : ENFC [SEQ ID NO: 659]

TABLE-US-00667 PEPTIDE : NFCT [SEQ ID NO: 660]

TABLE-US-00668 PEPTIDE : NFCTI [SEQ ID NO: 661]

TABLE-US-00669 PEPTIDE : FCTI [SEQ ID NO: 662]

TABLE-US-00670 PEPTIDE : AQQQQVYGSSIEQH [SEQ ID NO: 663]

TABLE-US-00671 PEPTIDE : AQQQQVYGSSIEQHSGQNIFSGF [SEQ ID NO: 664]

TABLE-US-00672 PEPTIDE : AAKRLQSQNDQRGE [SEQ ID NO: 665]

TABLE-US-00673 PEPTIDE : QARSLKNNRGEE [SEQ ID NO: 666] (also in P14614)

TABLE-US-00674 PEPTIDE : FNPSTNPWHSPRQGS [SEQ ID NO: 667] (a lso in Q0DEV5)

[0446] PROTEIN P14614 [SEQ ID NO: 668]

TABLE-US-00675 PEPTIDE : QARSLKNNRGEE (also in P14323) [SEQ ID NO: 668]

[0447] PROTEIN Q0D7S0 [SEQ ID NO: 669]

TABLE-US-00676 PEPTIDE : AAASLPAFCNVDIPNGGGGVCYWLAR [SEQ ID NO: 669]

[0448] PROTEIN Q0DEV5 [SEQ ID NOs: 670-680]

TABLE-US-00677 PEPTIDE : VAGSAPGIEGDEIAPLAK [SEQ ID NO: 670]

TABLE-US-00678 PEPTIDE : LGVAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 671]

TABLE-US-00679 PEPTIDE : GSAPGIEGDEIAPLAKE [SEQ ID NO: 672]

TABLE-US-00680 PEPTIDE : VAGSAPGIEGDEIAP [SEQ ID NO: 673]

TABLE-US-00681 PEPTIDE : GVAGSAPGIEGDEIAPLAK [SEQ ID NO: 674 ]

TABLE-US-00682 PEPTIDE : GVAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 6 75]

TABLE-US-00683 PEPTIDE : VAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 67 6]

TABLE-US-00684 PEPTIDE : SAPGIEGDEIAPLAK [SEQ ID NO: 677]

TABLE-US-00685 PEPTIDE : GSAPGIEGDEIAPLAK [SEQ ID NO: 678]

TABLE-US-00686 PEPTIDE : SAPGIEGDEIAPLAKEN [SEQ ID NO: 679]

TABLE-US-00687 PEPTIDE : FNPSTNPWHSPRQGS [SEQ ID NO: 680] (a lso in P14323)

[0449] PROTEIN Q9M3X6 [SEQ ID NOs: 681-699]

TABLE-US-00688 PEPTIDE : VDLVIPVNGPGK [SEQ ID NO: 681]

TABLE-US-00689 PEPTIDE : LVDLVIPVNGPGK [SEQ ID NO: 682]

TABLE-US-00690 PEPTIDE : IKLPAGTTSY [SEQ ID NO: 683]

TABLE-US-00691 PEPTIDE : IKLPAGTTSYL [SEQ ID NO: 684]

TABLE-US-00692 PEPTIDE : RRNPFLFKSNKF [SEQ ID NO: 685]

TABLE-US-00693 PEPTIDE : IENPVKELTFPGSVQEINR [SEQ ID NO: 686 ]

TABLE-US-00694 PEPTIDE : RRNPFLFKSNKFLT [SEQ ID NO: 687]

TABLE-US-00695 PEPTIDE : AKPHTIFLPQHIDA [SEQ ID NO: 688]

TABLE-US-00696 PEPTIDE : AKPHTIFLPQHIDAD [SEQ ID NO: 689]

TABLE-US-00697 PEPTIDE : KQKYRYQRE [SEQ ID NO: 690]

TABLE-US-00698 PEPTIDE : KQKYQYQRE [SEQ ID NO: 691]

TABLE-US-00699 PEPTIDE : MLPH [SEQ ID NO: 692]

TABLE-US-00700 PEPTIDE : RRNPFLFKSNKFLTLFENE [SEQ ID NO: 693 ]

TABLE-US-00701 PEPTIDE : PFLFKSNKFLTLFE [SEQ ID NO: 694]

TABLE-US-00702 PEPTIDE : SQERRNPFLFKSNKFLTLFE [SEQ ID NO: 69 5]

TABLE-US-00703 PEPTIDE : RRNPFLFKSNKFLTLFE [SEQ ID NO: 696]

TABLE-US-00704 PEPTIDE : SQERRNPFLFKSNKFLTLFENE [SEQ ID NO: 697]

TABLE-US-00705 PEPTIDE : LTFPGSVQE [SEQ ID NO: 698]

TABLE-US-00706 PEPTIDE : ELTFPGSVQEINR [SEQ ID NO: 699]

[0450] Rice Protein : Q0D9D0

TABLE-US-00707 MLCLTSSSSSAPAPLLPSLADRPSPGIAGGGGNVRLSVVSSPRRSWPGKV KTNFSVPATARKNKTMVTVVEEVDHLPIYDLDPKLEEFKDHFNYRIKRYL DQKCLIEKHEGGLEEFSKGYLKFGINTVDGATIYREWAPAAQEAQLIGEF NNWNGAKHKMEKDKFGIWSIKISHVNGKPAIPHNSKVKFRFRHGGGAWVD RIPAWIRYATFDASKFGAPYDGVHWDPPACERYVFKHPRPPKPDAPRIYE AHVGMSGEEPEVSTYREFADNVLPRIRANNYNTVQLMAIMEHSYYASFGY HVTNFFAVSSRSGTPEDLKYLVDKAHSLGLRVLMDVVHSHASNNVTDGLN GYDVGQNTHESYFHTGDRGYHKLWDSRLFNYANWEVLRFLLSNLRYWMDE FMFDGFRFDGVTSMLYHHHGINKGFTGNYKEYFSLDTDVDAlVYMMLANH LMHKLLPEATIVAEDVSGMPVLCRPVDEGGVGFDFRLAMAIPDRWIDYLK NKEDRKWSMSEIVQTLTNRRYTEKCIAYAESHDQSIVGDKTIAFLLMDKE MYTGMSDLQPASPTINRGIALQKMIHFITMALGGDGYLNFMGNEFGHPEW IDFPREGNNWSYDKCRRQWSLVDTDHLRYKYMNAFDQAMNALEEEFSFLS SSKQIVSDMNEKDKVIVFERGDLVFVFNFHPNKTYKGYKVGCDLPGKYRV ALDSDALVFGGHGRVGHDVDHFTSPEGMPGVPETNFNNRPNSFKVLSPPR TCVAYYRVDEDREELRRGGAVASGKIVTEYIDVEATSGETISGGWKGSEK DDCGKKGMKFVFRSSDEDCK [SEQ ID NO: 705]

[0451] Rice protein :Q6AVS5

TABLE-US-00708 MDRYQRVERPRPESAIEENEIRITAQGLIRNYVSYATSLLQDRRIKEIVL KAMGQAISKSVAVAEIIKKRVPGLYQDTNISSVSITDVWEPIEEGLVPLE MTRHVSMISITLSPRDLDKNSPGYQTPVYVEQPRQQPRLQQAPPPPQRQV RQPPPDYEDSYVRGRGRGRGRGRGRGWGRGGYGGYGGYGNNQGGYNQGGG YYDNQGGYGGYDNQGGYGGYDNQGGYGGGGYGYNQGRYGNYQENGGYNRG RGGMRGRGNWNYRGGYERGRGGGFPGGRGYGGRGRGRMGGRGGRGN[SEQ ID NO: 706]

[0452] Rice Protein: Q8H920

TABLE-US-00709 MALEHLGRRNVAGSLLLLNLLMYVFLLGFAGWALNSSIKNAGADVGVGWG EQPWSPYYRQSAWFASRFHLATFAALAGALGVAAKASAAYHGGRSGASWR PQGLAAAASLGTAAWAATALAFGVACREIHDAAAAGPAGAARGWRMRALE GLTVTLAFTQLLYVLLLHAAVAGERCGLACAADA [SEQ ID NO: 707 ]

[0453] Pea protein: O49927

TABLE-US-00710 MAIKTKLSLTIFLFFLLALLCSNLAVGRKEKDPELTTCKDQCDMQRQYDE EDKRICMERCDDYIKKKQERQKHKEHEEEEEQEQEEDENPYVFEDNDFET KIDTKDGRVLILNKFNEKSKLLKNIENYGLAVLEIKANAFLSPHHYDSEA ILFNIKGRGIIGLVAEDRTERFNLEEGDIMRVPAGTPMYLVNRDENEKLY IAAFHMPPSSGSAPVNLEPFFESAGRKPESVLNTFSSKVLQAALKSSKGE LETVLDEQKKGRIFKIEKEDVRGLAPKKSLWPFGGPFKSPFNIFSNNPAF SNKFGSLFEVGPSQEKSGLEGLNLMLTLANITKGSMSTIHYNTNANKIAL VIDGEGELEMACPHMPSSSSNSRQKKSSISYHNINAKLRPGVMFVVPAGH PFVNIASKKKNLIVVCFEVNAQRNKKLALAGKKNIVSALDKAAKEVAFDI AAEKVDEVFERKEEFFFPYDNEERKEEHGRAVV [SEQ ID NO: 708]

[0454] Pea protein :Q41000

TABLE-US-00711 MFRRATSTFLSRASATRRFSTDVATPATNSSFVEAWRKVSPNIDPPKTPL EFLKTRPPVPSTIPTKLTVNFVLPYSSQLAAKEVDSVIIPATTGEMGVLP GHVATIAELKPGVLTVQEGTDTTKYFVSSGFRFIHANSVADIIAVEAVPV NQLDRDLVQKGLQEFTQKLNSATTDLEKREAQIGIDVDSALNSALTG [S EQ ID NO: 709]

[0455] Rice Protein : P20698

TABLE-US-00712 MKIIFFFALLAIAACSASAQFDAVTQVYRQYQLQPHLMLQQQMLSPCGEF VRQQCSTVATPFFQSPVFQLRNCQVMQQQCCQQLRMIAQQSHCQAISSVQ AIVQQLRLQQFASVYFDQSQAQAQAMLALNMPSICGIYPSYNTAPCSIPT VGGIWY [SEQ ID NO: 710]

[0456] Pea Protein: O04434

TABLE-US-00713 MQDSSTMKFSPLDLMTAIIKGKFNPSNDSSQAPASIIFENREFVMILTTS IAVLIGCVVVLIWRRSNSNKSKQIEVPKLVIKKLPELDVDDGKKKVTVFF GTQTGTAEGFAKAIAEEAKARYEKAKFRVVDMDDYAADDDEYLEKLKRET MALFFLATYGDGEPTDNAARFYKWFTEEYEGEEDSFKNLSYGVFGLGNRQ YEHFNKVAKVVDDKLLEQGGKRLYPVGLGDDDQCIEDDFTAWKEELWPAL DQLLRDEDDTPVATPYTAAVSEYRVVIHDPLDATVDEKKRHNVNGHAVVD AQHPVRANVAVRRELHTPASDRSCTHLEFDISGTGVVYETGDHVGVYCEN LSDTVEEAERILGLSPDTYLSIHTDDEEGKPLGGSSLPPPFPPCTLRTAL TKYADLLSSPKKSALVALAAHASDPSEADRLRHLASPAGKDEYAEWVISS QRSLLEVMAEFSSAKPPIGVFFAAVAPRLQPRYYSISSSPRMAPSRIHVT CALVHDKMPTGRIHKGVCSTWMKNSVPLEKNQDCSWAPIFVRQSNFRLPA DNKVPVIMIGPGTGLAPFRGFLQERLALKEDGAELGPSVLFFGCRNRQVD YIYEDELNHFVNGGALSELIVAFSRDGPTKEYVQHKMMEKASDIWNMISQ GAYVYVCGDAKGMARDVHRTLHTILQEQGSLDSSKTESMVKNLQMTGRYL RDVW [SEQ ID NO: 711]

[0457] Rice Protein : Q5N725

TABLE-US-00714 MSAYCGKYKDELIKNAAYIGTPGKGILAADESTGTIGKRFASINVENVEE NRRSLRELLFTTPGALQHLSGVILFEETLYQKTKDGKPFVDVLKEGGVLP GIKVDKGTVEVAGTNKETTTQGHDDLGKRCAKYYEAGARFAKWRAVLKIG PNEPSQLSIDLNAQGLARYAIICQENGLVPIVEPEILVDGSHDIERCAYV TEKVLAACYKALNEHHVLLEGSLLKPNMVTPGSESKKVSPQLIAEYTVRA LQRTVPAAVPAIVFLSGGQSEEEATVNLNAMNKLSTKKPWALSFSFGRAL QQSTLKAWGGKTENVVKAQKAFITRCKANSEATLGTYQGDAVLGEGASES LHVKDYKY[SEQ ID NO: 712]

[0458] Pea Protein: B5A8N6

TABLE-US-00715 MASLQTQMISFYAIFLSILLTTILFFKVNSTETTSFLITKFSPDQQNLIF QGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFV INAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEF DTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANVVIAFNAAT NVLTVSLTYPNSLEEENVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYA AHEVLSWSFHSELSGTSSSKQAADA [SEQ ID NO: 713]

[0459] Rice Protein: Q6K508

TABLE-US-00716 MATTTSLLSSCLCALLLAPLFSQGVDAWESRQGASRQCRFDRLQAFEPLR KVRSEAGDTEYFDERNEQFRCAGVFVIRRVIEPQGLVVPRYSNTPALAYI IQGKGYVGLTFPGCPATHQQQFQLFEQRQSDQAHKFRDEHQKIHEFRQGD VVALPASVAHWFYNGGDTPAVVVYVYDIKSFANQLEPRQKEFLLAGNNQR GQQIFEHSIFQHSGQNIFSGFNTEVLSEALGINTEASKRLQSQNDQRGDI IRVKHGLQLLKPTLTQRQEEHRQYQQVQYREGQYNGLDENFCTIKARVNI ENPSRADYYNPRAGRITLLNNQKFPILNLIGMGAARVNLYQNALLSPFWN INAHSVVYIIQGSVRVQVANNQGRSVFNGVLHQGQLLIIPQNHAVIKKAE HNGCQYVAIKTISDPTVSWVAGKNSILRALPVDVIANAYRISRDEARRLK NNRADEIGPFTPRFPQKSQRGYQFLTEGLSLIGM [SEQ ID NO: 714 ]

[0460] PEA PROTEIN : Q712V4

TABLE-US-00717 QKAPRKQLATKAARKSAPATGGVKKPHRFRPGTVALREIRKYQKSTELLI RKLPFQRLVREIAQDFKTDLRFQSSAVSALQEAAEAYLVGLFEDTNLCAI HAKRVTIMPKDIQLARRIRGERA [SEQ ID NO: 715]

[0461] Pea Protein: P09886

TABLE-US-00718 MAQSVSLSTIASPILSQKPGSSVKSTPPCMASFPLRRQLPRLGLRNVRAQ AGGDGDNKDNSVEVHRVNKDDQGTAVERKPRRSSIDISPFGLLDPWSPMR SMRQMLDTMDRIFEDAITIPGRNIGGGEIRVPWEIKDEEHEIRMRFDMPG VSKEDVKVSVEDDVLVIKSDHREENGGEDCWSRKSYSCYDTRLKLPDNCE KEKVKAELKDGVLYITIPKTKIERTVIDVQIQ [SEQ ID NO: 716]

Examples of Homologs for Each Protein

P13918 (Pea)

[0462] >gi| 137584 | sp | P08438.1 | VCL_ VICFA RecName: Full=Vicilin; Flags: Precursor [Vicia faba] >gi| 22057 | emb | CAA68559.1| vicilin [Vicia faba var. minor] >gi|383931031|gb|AFH56916.1| vicilin [Vicia faba]

TABLE-US-00719 MAATTLKDSFPLLTLLGIAFLASVCLSSRSDQDNPFVFESNRFQTLFENE NGHIRLLQKFDQHSKLLENLQNYRLLEYKSKPHTIFLPQQTDADFILVVL SGKAILTVLLPNDRNSFSLERGDTIKLPAGTIGYLVNRDDEEDLRVLDLV IPVNRPGEPQSFLLSGNQNQPSILSGFSKNILEASFNTDYKEIEKVLLEE HGKEKYHRRGLKDRRQRGQEENVIVKISRKQIEELNKNAKSSSKKSTSSE SEPFNLRSREPIYSNKFGKFFEITPKRNPQLQDLNIFVNYVEINEGSLLL PHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEYDEEKEQGEEEIRK QVQNYKAKLSPGDVLVIPAGYPVAIKASSNLNLVGFGINAENNQRYFLAG EEDNVISQIHKPVKELAFPGSAQEVDTLLENQKQSHFANAQPRERERGSQ EIKDHLYSILGSF [SEQ ID NO: 506]

[0463] >gi|502105533| ref|XP_004492829.1| PREDICTED: vicilin-like isoform X1 [Cicer arietinum] ChickPea

TABLE-US-00720 MAIKARFPLLVLLGIVFLASVCAKSDKENPFFFKSNNCQTLFENENGHVR LLQRFDKRSQLFENLQNYRLMEYNSKPHTLFLPQHNDADFILVVLRGRAI LTVLNPNDRNTFKLERGDTIKLPAGTIAYLANRDDNEDLRVLDLAIPVNR PGQFQSFSLSGNENQQSYFQGFSKKILEASFNSDYEEIERVLLEEQEQKP EQRRGHKGRQQSQETDVIVKISREQIEELSKNAKSNCKKSVSSESEPFNL RSRSPIYSNRFGNFFEITPEKNPQLKDLDIFVNSVEIKEGSLLLPHFNSR ATVILVVNEGKGEVELVGLRNENEQENKKEDEEEEEDRNVQVQRFQSKLS SGDVVVIPASHPFSINASSDLFLLGFGINAQNNQRNFLAGEEDNVISQIQ RPVKEVAFPGSAEEVDRLLKNQRQSHFANAQPQQKRKGSQRIRSPF [SE Q ID NO: 507]

[0464] >gi |29539109| emb |CAD87730.1| allergen Len c 1.0101 [Lens culinaris] Lentil

TABLE-US-00721 SRSDQENPFIFKSNRFQTIYENENGHIRLLQRFDKRSKIFENLQNYRLLE YKSKPHTIFLPQFTDADFILVVLSGKAILTVLNSNDRNSFNLERGDTIKL PAGTIAYLANRDDNEDLRVLDLAIPVNRPGQLQSFLLSGTQNQPSFLSGF SKNILEAAFNTEYEEIEKVLLEEQEQKSQHRRSLRDKRQEITNEDVIVKV SREQIEELSKNAKSSSKKSVSSESEPFNLRSRNPIYSNKFGKFFEITPEK NPQLQDLDIFVNSVEIKEGSLLLPNYNSRAIVIVTVNEGKGDFELVGQRN ENQQEQREENDEEEGQEEETTKQVQRYRARLSPGDVLVIPAGHPVAINAS SDLNLIGFGINAKNNQRNFLAGEEDNVISQIQRPVKELAFPGSSREVDRL LTNQKQSHFANAQPLQIE [SEQ ID NO: 508]

Q9M3X6 (Pea)

[0465] >gi |164512526| emb |CAP06312.1| cvc [Pisum abyssinicum]

TABLE-US-00722 MATTVESRFPLLLFPGIIFLASVCVTYANYDEGSETRVPGQRERGRQEGE KEEKRHGEWRPSYEKEEDEEEKQKYRYQREKEDEEEKQKYRYQREKKEEK EVQPGRERWEREEDEEQVDEEWRGSQRRQDPEERARLRHREERTKRDRRH KREGEEEERSSESQEQRNPFLFKSNKFLTLFENENGHIRRLQRFDKRSDL FENLQNYRLVEYRAKPHTIFLPQHIDADLILVVLNGKAILTVLSPNDRNS YNLERGDTIKIPAGTTSYLVNQDDEEDLRVVDFVIPVNRPGKFEAFGLSE NKNQYLRGFSKNILEASLNTKYETIEKVLLEEQEKKPQQLRDRKRRQQGG ERDAIIKVSREQIEELRKLAKSSSKKSLPSEFEPFNLRSHKPEYSNKFGK LFEITPEKKYPQLQDLDILVSCVEINKGALMLPHYNSRAIVVLLVNEGKG NLELLGLKNEQQEREDRKERNNEVQRYEARLSPGDVVIIPAGHPVAISAS SNLNLLGFGTNAENNQRNFLSGSDDN [SEQ ID NO: 509]

[0466] >gi 11645125381 emb |CAP06318.1| cvc [Lathyrus annuus]

TABLE-US-00723 MATTIKSRFPLLLLLGIIFLASVCVTWANYDEGSEPRVPGQRERGRQEGE KEEKRHGEWRPSYEEEYDEGLEPKVPGKRERGRQEGEKEEKRHEEWRPSY EKEEDEEEKQKYNYQREKKEHKEVQPGRERWERKQDEKQVEEDEEPGEEQ WRGSKRHEDPEERARLRHREEKTKSYVEDNEETSSKEGRNPFLFKSNKFL TLFENENGHIRRLQRFDERSDIFENLQNYRLVEYRAKPHTMFLPQHIDAD LlLVVLNGKAILTVLSPNDRNSYNLERGDTVKLPAGTTSYLVNQDDEEDL RVVDLAIPVNRPGKFEAFGLSANKNQYLRGFSKNILEASLNTKYETIEKV LLEERRDQKGRQQGQETNAIVKVSREQIEELRKLAKSSSKKSLLSESEPL NLRSQNPKYSNKFGKFFEITPQKKYPQLQDLDVSISCVEINKGALLLPHY NSRSIGILLVNEGKGNLELVGFKNEQQRQRENEETNKKLQRYEARLSSGD VVVIPEGHPVAISASSNLNLLGFGINAANNQRNFLTGSDDN [SEQ ID NO: 510]

[0467] >gi 11645125581 emb |CAP06328.1| cvc [Vicia villosa]

TABLE-US-00724 MATTIKSRFPVLLLLGIIFLTSVCVTYANYDEGREPSVPGQRERGRQEGE KEEKRHGEWRPSEEDEEEKYKYEEGRVPGQRERGRQEGEKEEKRHGKWRP SEEEDEEEKYRYEEGSEPRGPGQRETGRQEGEKEKQRPEREPSYEKEEDE EEKQKYQYHREKKEQREVRPGRERFERHEDEEQWRGIQRHEDPEERARER YRAEIAKRQVEEEREERDIPHEREQRNPFLFKSNKFQTLFQNENGYIRRL QRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLIIVVLSGRAILT VLSPDDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPG KVESFLLSGNKNQYLRGFSKNILEASFNTNYETIERVLLEEQDKESQQSI GQKRRSQRQETNALVKVSREQLEDLKRLAKSSSQEGLSSQFEPINLRSQN PKYSNKFGKVFEITPEKKYPQLQDLDLFVSSVDIKEGALMLPHYNSRAIV VLLVNEGRGNLELVGLKNEQQEQREKEDEQQERNNQVQRYEARLSPGDVV IIPAGHPVAVRASSDLNLLAFGINAENNQRNFLAGSDDN [SEQ ID NO : 511]

P09918 (Pea)

[0468] >gi |357454557| ref| XP_003597559.1 | Seed lipoxygenase-3 [Medicago truncatula] >gi | 355486607 |gb | AES67810.1 | seed linoleate 9S-lipoxygenase [Medicago truncatula]

TABLE-US-00725 MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTSVGGVIGQGFDILGSTL DNLTAFLGRSVSLQLISATKPDAN GKGKLGKATFLEGIITSLPTLGAGQ SAFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIYFVCN SWIYNAKHHKLDRIFFANKAYLPSETPAPLVHYREEELNNLRGDGTGERK EWERIYDYDVYNDLGNPEKGDNHARPVLGGSDTYPYPRRGRTGRKPNPKD PKSESRSDFVYLPRDEAFGHLKSSDFLTYGLKAVSQNVVPALESVIFDLN FTPNEFDSFDEVHGLYEGGIKLPTDVLSKISPLPVLKEIFRTDGEQFLKY PPPKVLQVSRSAWMTDEEFAREMLAGVNPNVICCLQEFPPRSKLDSQVYG DHTSKITKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTPT KAYATRTILFLSSDKTLKPLAIELSLPHPDGDEHGAVSHVYQPALEGVES TIWLLAKAYVVVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSYLHPIYK LLYPHYRDTMNINSLARQSLVNDGGIEKTFLWGRYSMEMSSKVYKNWTLP GQALPADLIKRGMAIEEPSSPCGVKLVVEDYPYAHDGLEIWAAIKTWVQD YVSLYYTTDDILRQDSELQAWWKELVEVGHGDKKNEPWWPKMQAREELVE VCTTVIWIASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEYNELV KSPQKAYLKTITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTR ALEAFKKFGNKLAEIEKNLAQRNNDEKLRHRLGPVQMPYTLLHPSSEEGL TFRGIPNSISI [SEQ ID NO: 512]

[0469] >gi |734403888|gb | KHN32710.1| Seed linoleate 9S-lipoxygenase-3 [Glycine soja]

TABLE-US-00726 MLGGLLHRGHKIKGTVVLMRKNVLDVNSVTSVGGIIGQGLDLVGSTLDTL TAFLGRSVSLQLISATKADANGKGKLGKATFLEGIITSLPTLGAGQSAFK INFEWDDGSGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIHFVCNSWIY NAKLFKSDRIFFANQTYLPSETPAPLVKYREEELHNLRGDGTGERKEWER IYDYDVYNDLGDPDKGENHARPVLGGNDTFPYPRRGRTGRKPTRKDPNSE SRSNDVYLPRDEAFGHLKSSDFLTYGLKSVSQNVLPLLQSAFDLNFTPRE FDSFDEVHGLYSGGIKLPTDIISKISPLPVLKEIFRTDGEQALKFPPPKV IQVSKSAWMTDEEFAREMLAGVNPNLIRCLKDFPPRSKLDSQVYGDHTSQ ITKEHLEPNLEGLTVDEAIQNKRLFLLDHHDPIMPYLRRINATSTKAYAT RTILFLKNDGTLRPLAIELSLPHPQGDQSGAFSQVFLPADEGVESSIWLL AKAYVVVNDSCYHQLVSHWLNTHAVVEPFIIATNRHLSVVHPIYKLLHPH YRDTMNINGLARLSLVNDGGVIEQTFLWGRYSVEMSAVVYKDWVFTDQAL PADLIKRGMAIEDPSCPHGIRLVIEDYPYAVDGLEIWDAIKTWVHEYVFL YYKSDDTLREDPELQACWKELVEVGHGDKKNEPWWPKMQTREELVESCAI IIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEKGSAEYEELRKNPQ KAYLKTITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEA FKRFGNKLAQIENKLSERNNDEKLRNRCGPVQMPYTLLLPSSKEGLTFRG IPNSISI [SEQ ID NO: 513]

[0470] >gi | 593700103| ref|XP_007150490.1| hypothetical protein PHAVU_005G157000g [Phaseolus vulgaris] >gi|561023754|gb | ESW22484.1| hypothetical protein PHAVU_005G157000g [Phaseolus vulgaris]

TABLE-US-00727 MFSGVSGLINRGHKLKGTVVLMRKNVLDVNSVTSVGGIVGQGLDILGSTV DNLTAFLGRSVSLQLISATKPDANGKGKLGKATFLEGIITSLPTLGAGQS AFKIHFEWDDEMGIPGAFYIKNFMQTEFYLVSLTLEDIPNHGSLHFLCNS WIYNAKHFKNDRIFFVNQIYLPSETPAPLVKYREEELVNMRGDGTGERKE WDRIYDYDVYNDLGDPDKGENNARPILGGSDTLPYPRRGRTGRRPTRKDP KSESRSSDIYLPRDEAFGHLKSSDFLTYGLKSVSQNFLPALQSAFDLNFT PNEFDSFEEVHGLYSGGIKLPTDVLSKISPLPVLKEIFRTDGEQTLKFPP PKVVQDSKSAWMTDEEFAREMICGVNPNLIRLLQDFPPQSKLDSQVYGDH TSQITKENLEPNLEGLTVDEAIQSKRLFLLDHHDSIMPYLRRINATSSKA YATRTILFLKKDRTLKPLAIELSLPHPGGDKSGVVSQVFLPADEGVESSV WLLAKSYVIVNDSSYHQLVSHWLNTHAVVEPFVIATNRHLSVVHPIYKLL HPHYRDTMNINALARGDLVNHGGIIEKTFVWGRYSMEMSAVIYKDWVFTD QALPADLIKRGIATEDPECPHGLRLFIEDYPYAVDGLEIWDAIKTWVHEY VFLYYKSDDTLKEDPELQAWWKELVEVGHGDKKNEPWWPKMQTREELVEA CSIVIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEEGSAEYEELKK SPQKALLKTITPKFQTLVDLSVIEILSRHASDEVYLGERDNPNWTSDTRA LEAFKRFGKKLSEIEKKLSQRNNDEKLRNRYGPVMMPYTLLFPSSDEGLT FRGIPNSISI [SEQ ID NO: 514]

P02857 (Pea)

[0471] >gi |483449| emb |CAA83677.1| legumin A [Vicia sativa]

TABLE-US-00728 MAKLLALSLSFCFLLFSSCFALREQSQQNECQLERINALEPDNRIESEGG LIETWNPNNRQFRCARVALSRATLQRNALRRPYYSNAPQEIYIQQGNGYF GMVFPGCPETHEEPQQSEQGEGRRYRDSHQKVNRFREGDIIAVPTGIAFW MYNDQDTPVIAISLTDTGSSNNQLDQMPRRFYLAGNQEQEFLRYQHQQGG KQEQDNDGNNIFSGFKRDFLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVK GGLSIIAPPERQARHERGSRQEEDEDEKEERQPSHHKSRRDEDEDDKEKR HSQKGQSRRQGDNGLEETVCTAKLRANIGSSPSPDIYNPQAGRIKTVTSL DLPVLRWLKLSAEHGSLHKNAMFVPHYNLNANSVIYALKGRARLQVVNCN GNTVFDGELEAGRALTVPQNYAVAAKSLSERFTYVAFKTDDRASIARLAG TSSVIDDLPLDVVAATFNMQRNEARQLKSNNPFKFLVPPRQSEMRASA [ SEQ ID NO: 515]

[0472] >gi |600108| emb |CAA86824.1| legumin A precursor [Vicia narbonensis]

TABLE-US-00729 MAKLLALSLSLCFLLFSNSFALREQSQQNECQLERLDALEPDNRIESEGG LIETWNPNNRQFRCAGVALSRVTLQRNALRRPYYSNAPQEIYIQQGNGYF GVVFPGCPETFEEPQESEQRERRRYRDSHQKVNRFREGDIIAVPTGNVLW MYNDQDTPVIAISLTDTGSSNNQLDQIPRRFYLAGNQEQEFLRYQREQGG KQEQENDGNNIFSGFKRDFLEDALNVNRHIVDRLQGRNEDEEKGAIVKVK GGLSIITPPERQRGSRQEEDEDEKEERQPSRRRDESQKGESRRHGDNGLE ETVCTAKLRVNIGSSPSPDIYNPQAGRINTVTSLDLPVLRWLKLSAEHGS LRKNALIVPHYNRNANSVIYALKGRARLQVVNCNGNTVFDGELEAGRALT VPQNYAVAAKSLSERFTYVAFKTNDRDGIARLAGTSSVINDLPLDVVAAT FNLQRNEARQLKSNNPFKLLVPPRESEKRASA [SEQ ID NO: 516]

[0473] >gi|502110016| ref|XP_004493779.1| PREDICTED: legumin-like [Cicer arietinum]

TABLE-US-00730 MAKLLALSLSFCFLLFGSCFALRDQPEQNECQLEHLNALEPDNRIKSEGG LIETWNPSNKQFRCAGVALSRATLQPNSLRRPFYTNAPQEIFIQQGNGYF GMVFPGCVETFEEPRESEQGEGSKFRDSHQKVNRFREGDIIAVPTGVVFW MFNDQDTPVIAVSLIDTSSFQNQLDQMPRRFYLAGNHEXXXXXXXXQQEG SEEEENEGGNIFSGFKRDFLEDALNVNRRIVNKLQGRNEDEEKGAIVKVK GGLSIITPPEKEPRQKRGSRQEEDEDEDEKRQPHRHSRQDEDEDEKRQPR RHSRGGSKSQRDNGFEETICTARLHQNIGSSSSPDIYNPQAGRIKTVTSF DLPALRFLKLSAEFGSLHKNAMFVPHYNLNANSILYALKGRARLQIVNCK GNSVFDGELEAGRALIVPQNFAIAAKSLSDRFSYVAFKTNDRAAIGRLLG ASSLINGMPEEVVAAAFNMERNEARQLKFNSPFSFLVPPRSDSDNKAAA [SEQ ID NO: 517]

P02855 (Pea)

[0474] >gi |164512536| emb |CAP06317.1| cvc [Lathyrus hirsutus]

TABLE-US-00731 MAIIIKSRFPLLLLLGIIFLASVCATWANYDEGSEPRVPGQRERGRQEGE KAEKSHEKWRPSYEEEYDEGSEPRVPGKRERGRQEGEKEEKRHGEWRPSH EEEYDEGSEPRVPTHGERGRQEGEKEEKRHEEWRPSYEKEEDEEEKEKYK YQREKKEQKEVQPGREKWERKQDEKHVEEDEDQEEEQWRGSKRREDPEER ARLRYREERTKSNVEEETEERRNPFLFKSNKFLTLFENENGHIRRLQRFD ERSDIFENLQNYRLVEYKAKPHTMFLPQHIDADLIIVVLNGKAILTVLSP NDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKFEA FGLSANKNQYLRGFSKNILEAFLNTKYETIEKVLLEEQERRDRKGRQQGQ ETNAIVKVSREQIEELRKLAKSSSKKSLLSESEPINLRSQNPKYSNKFGK LFEITPEKKYPQLQDLDVSISCVEINEGAPLLPHYNSRAIVLLLVNEGKG NLELVGFKNEQQRQRENEERNKKVQRYEARLSPGDVVVIPAGHPVAISAS LNLNLVGFGVNAENNQRNFLTGSDDN [SEQ ID NO: 518]

[0475] >gi |164512542| emb |CAP06320.1| cvc [Lathyrus cicera]

TABLE-US-00732 MATIIKSRFPLLLLLGIIFLASVCVTLANYDEGSEPRVPAQRERGRQEGE KEEKRHGEWRPSHEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGEWRPSY EKEYDEGSEPRVPGRRERGRQEGEKEEKRHGEWRPSYEKEYDEEEKQKYQ YEREKEEQKEVQPGRERWERKEDEEKEEDQWRGSQRHEDPEERARLRYRK ERTKKYVEEDTEETSSESQGRRNPFLFKSNKFLTLFENENGYIRRLQRFD ERSDIFENLQNYRLVEYRAKPHTIFLPQHIDADLILVILNGKAILTVLSP NDRNSYNLERGDTIKLPAGTTSYLVNEDDEEDLRVVDLVIPVNRPGKFEA FDLNQYLGGFSKSVLEASLNTKYETIEKVLLEEQQKQGQETNAIVKVSRE QIEELRKLAKSSSKKSLLSELEPVNLRSHSPKYSNKFGKFFEITPEKKYP QLQDLDVSISCVEINEGALLLPHYNSRAIVVVLVNEGKGNLELLGVQNED EQQERKERNKEVQRYEARLSPGDVVIIPSGHPVAVSASSNLNLLGFGINA ENNQRNFLSGSDDN [SEQ IDNO: 519]

[0476] >gi 11645125441 emb |CAP06321.1| convicilin [Lathyrus sativus]

TABLE-US-00733 MATIIKSRFPLLLLLGIIFLASVCVTYANYDEGSEPRVPAQRERGRQEGE KEEKRHGEWRPSSEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGEWRPSY EKEYDEEEKQKYQYEREKKEQKEVEPGRERWERKEDEEKEEDQWRGSQRH EDPEERARLRYRKERTKKYVEEDTEETSSESQGRRNPFLFKSNKFLTLFE NENGYIRRLQRFDERSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLILV ILNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTSYLVNEDDEEDLRVVD LVIPVNRPGKFEAFDLNQYLGGFSKSVLKASLNTKYETIEKVLLEEQQKQ GQETNAIVKVSREQIEELRKLAKSSSKKSLLSELEPVNLRSHSPKYSNKF GKFFEITPEKKYPQLQDLDVSISCVEINEGALLLPHYNSRAIVVLLVNEG KGNLELLGVQDEDEQQERKKRNKEVQRYEARLSPSDVVIIPAGHPVAVSA SSNLNLLGFGINAENNERNFLSGSDDN [SEQ ID NO: 520]

D3VNE1 (Pea)

[0477] >gi|357507721| ref|XP_003624149.1| Provicilin [Medicago truncatula] >gi | 87162569 |gb| ABD28364.1| Cupin, RmlC-type [Medicago truncatula] >gi|355499164 | gb | AES80367.1| vicilin 47 kDa protein [Medicago truncatula]

TABLE-US-00734 MAIKAPFQLLMLLGIFFLASVCVSSRDDRHDQENPFFFNANHFQTLFENE NGHIRLLQRFDKRSKIFENLQNYRLLEYHSKPHTLFLPQHNDADFILAVL SGKAILTVLNPDNRNSFNLERGDTIKLPAGSIAYLANRDDNEDLRVLDLA IPVNRPGKFQSFSLSGSQNQQSFFSGFSKNILEAAFNANYEEIERVLIEE HEQEPQHRRGLRKDRRQQSQDSNVIVKVSREQIEELSRHAKSSSRRSGSS ESAPFNLRSREPIYSNEFGNFFEITPEKNPQLKDLDILVNYAEIREGSLL LPHFNSRATVIVVVDEGKGEFELVGQRNENQQEQREEDEQQEEERSQQVQ RYRARLSPGDVYVIPAGHPTVVSASSDLSLLGFGINAENNERNFLAGEED NVISQIERPVKEVAFPGSAQDVESLLKNQRQSYFANAQPQQREREEGRSQ RQRELISSILGVF [SEQ ID NO:521]

[0478] >gi | 164512560|emb|CAP06329.1| convicilin [Vicia peregrina]

TABLE-US-00735 MATTFKSRFSLLLLLGIIFLAFVCVTCANYDEGSEPRVPGQRERGRQEGE KEEQSRERHPQREPSREKEEDEEEKQKYDEGTEPRVPGQRERGRQEGEKE EQRRERHPGQREPSQEEDEEREESDRRQEGSSKSEEQRNPFLFKSNKFLT LFQNGNGHIRLLQRFDKRSDLFENLQNYRLLEYRAKPHTIFLPQHIDADL ILVVLSGRAILTVLSPDDRNSYNLERGDTIKLPAGTTSYPLNQDDEEDLR VVDLAISVNRPGKVESFNLSGNKNQYLRGFSENILEASFNTKYETIEKVL LEEQDKESQQPRGQRLQRQETNALVKVSREQVEELKRLARTSSKKGVSSE FEPFNLRSHGPKYSNKFGKFFEITPEKKYPQLQDLDISVSSVEINEGALF LPHYNSRAIVVVLVDEGKGNLELVGFKNEQQEQREKEDEQEERNKQVQRY EAKLSPGDVVIIPAGHPVAVSASSNLNLLGFGINAENNQRNFLTGSDDN [SEQ ID NO: 522]

[0479] >gi | 164512562 |emb|CAP06330.1| convicilin [Vicia lutea]

TABLE-US-00736 MATTIKLRFPLLLLLGVILLASVCVTCANYDEGSEPRVPGRPEGEKEEKH RGKLRPSYEKEEDEGEKQRYHYEKKEQKEAQPRREKKEQKEEEKQVEEES RESQRYEDPGERARERYRAEIIKRQVEKEREERDRRHQREGEEEEGSSKS RNPFLFKSNNFLTLFENENGHIRLLQRFDKRSDLFENLQNYRLVEYRAKP HTIFLPQHIDADLILVVLSGKAILTVLSPNNRNSYNLKRGDTIKLPAGTT SYLLNSDDEEDLRMVDLAISVNRPGKVESFNLSGNKNQYLRGFSKNILEA SFNTKYETIEKVLLEEQDKESQQSIGQKRISQRQETNALVKVSREQIEEP KRLARSSSRKGVSSEFEPINLRSQRPKYSNKFGKFYEISPEKKYPQLQDL DVSVSSVEINEGALLLPHYNSRAIVTVLVNEGKGNLELIGFQNEQQGQRE KEDEQQHERNKQVQRYDARLSSGDVVIIPAGHPVAVSASSNLDLLGFGIN AENSQRNFLTGSDDN [SEQ ID NO: 523]

P07728 (Rice)

[0480] >gi |531874314| gb |AGT59174.1| glutelin, partial [Oryza sativa Indica Group]

TABLE-US-00737 CRFDRLQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSAVRRVIEPRGLL LPHYTNGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLTESQSQS HKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVTDLNNGAN QLDPRQRDFLLAGNKRNPQAYRREVEERSQNIFSGFSTELLSEALGVSSQ VARQLQCQNDQRGEIVRVEHGLSLLQPYASLQEQEQGQVQSRERYQEGQY QQSQYGSGCSNGLDETFCTMKVRQNIDNPNRADTYNPRAGRVTNLNTQNF PILNLVQMSAVKVNLYQNALLSPFWNINAHSVVYITQGRARVQVVNNNGK TVFNGELRRGQLLIIPQHYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKS SIFRALPNDVLANAYRISREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNA AESS [SEQ IDNO: 524]

[0481] >gi | 109894635|gb|ABG47337.1| glutelin precursor [Zizania latifolia]

TABLE-US-00738 MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFD RLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRGLLLPQY TNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFK DEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVIDINNAANQLDP RQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQ LQCQNDQRGEIVRVEHGLSLLQPYASLQEQEQKQEQPRERYQVTQHQQSQ YGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILN LIQMSAVKVNLYQNALLSPFWNINSHSVVYVTQGCARVQVVNNNGKTVFN GELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFR ALPTDVLANAYRISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID NO: 525]

[0482] >gi |472867| emb | CAA52764.1 | 11S globulin [Avena sativa]

TABLE-US-00739 MATTSFPSMLFYFCIFLLFHGSMAQLFGQSSTPWQSSRQGGLRGCRFDRL QAFEPLRQVRSQAGITEYFDEQNEQFRCTGVSVIRRVIEPQGLVLPQYHN APALVYILQGRGFTGLTFPGCPATFQQQFQPFDQSQFAQGQRQSQTIKDE HQRVQRFKQGDVVALPAGIVHWCYNDGDAPIVAIYVFDVNNNANQLEPRQ KEFLLAGNNKREQQSGNNIFSGLSVQLLSEALGISQQAAQRIQSQNDQRG EIIRVSQGLQFLKPIVSQQVPGEQQVYQPIQTQEGQATQYQVGQSTQYQV GKSTPYQGGQSSQYQAGQSWDQSFNGLEENFCSLEARKNIENPQHADTYN PRAGRITRLNSKNFPILNIVQMSATRVNLYQNAILSPFWNINAHSVIYMI QGHARVQVVNNNGQTVFNDILRRGQLLIVPQHFVVLKKAEREGCQYISFK TNPNSMVSHIAGKSSILRALPIDVLANAYRISRQEARNLKNNRGEEFGAF TPKLTQKGFQSYQDIEEGSSSPVRASE [SEQ ID NO: 526]

P14614

[0483] >gi |115445309| ref| NP_001046434.1| Os02g0248800 [Oryza sativa Japonica Group] >gi|37993738|gb|AAR06952.1| glutelin type-B [Oryza sativa Japonica Group] >gi |47497729| dbj | BAD19794.1| glutelin type-B [Oryza sativa Japonica Group] >gi |113535965| dbj | BAF08348.1| Os02g0248800 [Oryza sativa Japonica Group] >gi 12157689421 dbj | BAH01171.1| unnamed protein product [Oryza sativa Japonica Group] >gi| 284431772 |gb|ADB84627.1| glutelin [Oryza sativa Japonica Group]

TABLE-US-00740 MTISVFSRFSlYFCVLLLCNGSMAQLFDPATNQWQTHRQGSFRECRFERL QAFEPLQNVRSEAGVTEYFDETNELFQCTGTFVIRRVIQPQGLLIPRYAN TPGMVYIIQGRGSMGLTFPGCPATYQQQSQQFLFQGESQSQKFIDEHQKI HQFRQGDIVVLPTGVAHWFYNDGDTPVVALYVYDINNSANQLEPRHREFL LAGKNNRVQQVYGRSIQQHSGQNIFNGFSVEPLSEALNINTVTTKRLQSQ NDQRGEIIHVKNGLQLLKPTLTQRQEQEQAQYQEVQYSEKPQTSSRWNGL EENLCTIKTRLNIENPSRADSYDPRAGRITSLDSQKFPILNIIQMSATRV NLYQNAILTPFWNVNAHSLMYVIRGRARVQVVSNFGKTVFDGVLRPEQLL IIPQNYVVLKKAQHEGCQYIAINTNANAFVSHLAGVDSVFHALPVDVIAN AYCISREEARRLKNNRGDEYGPFPPRLQQQIYPEFSNESKGETSE [SEQ ID NO: 527]

[0484] >gi |428674402|gb|AFZ41188.1| glutelin, partial [Oryza sativa Japonica Group]

TABLE-US-00741 LLCHGSMAQIFSLGINPWQNPRQGGSRECRFDRLQAFEPLRKVRHEAGVT EYFDEKNEQFQCTGTLVIRRIIEPQGLLLPRYSNTPGLVYIIQGTGVLGL TFPGCPATYQKQFRHFGLEGGSQRQGKKLRDENQKIHQFRQGDVVALPSG IPHWFYNEGDTPVVALFVFDVNNNANQLEPRQKEFLLAGNNIEQQVSNPS INKHSGQNIFNGFNTKLLSEALGVNIEVTRRLQSQNDRRGDIIRVKNGLR LIKPTITQQQEQTQDQYQQIQYHREQRSTSKYNGLDENFCAIRARLNIEN PNHADTYNPRAGRITNLNSQKFSILNLVQMSATRVNLYQNAILSPFWNIN AHSLVYTIQGRARVQVVSNHGKAVFNGVLRPGQLLIIPQNYVVMKKAELE GFQFIAFKTNPNAMVNHIAGKNSVLRAMPVDVIANAYRISRQEARSLKNN RGEEIGAFTPRYQQQKIHQEYSNPNESETQ [SEQ ID NO: 528]

[0485] >gi|226510|prf||1515394A seed storage globulin

TABLE-US-00742 MATTRFPSLLFYSCIFLLCNGSMAQLFGQSFTPWQSSRQGGLRGCRFDRL QAFEPLRQVRSQAGITEYFDEQNEQFRCAGVSVIRRVIEPQGLLLPQYHN APGLVYILQGRGFTGLTFPGCPATFQQQFQPFDQARFAQGQSKSQNLKDE HQRVHHIKQGDVVALPAGIVHWCYNDGDAPIVAVYVFDVNNNANQLEPRQ KEFLLAGNNKREQQFGQNIFSGFSVQLLSEALGISQQAAQKIQSQNDQRG EIIRVSQGLQFLKPFVSQQGPVEHQAYQPIQSQQEQSTQYQVGQSPQYQE GQSTQYQSGQSWDQSFNGLEENFCSLEARQNIENPKRADTYNPRAGRITH LNSKNFPTLNLVQMSATRVNLYQNAILSPYWNINAHSVMHMIQGRARVQV VNNHGQTVFNDILRRGQLLIIPQHYVVLKKAEREGCQYISFKTTPNSMVS YIAGKTSILRALPVDVLANAYRISRQESQNLKNNRGEEFGAFTPKFAQTG SQSYQDEGESSSTEKASE [SEQ ID NO: 529]

P07730 (Rice)

[0486] >gi|225959| prf| |1404367A glutelin

TABLE-US-00743 MASTNRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDR LQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGLLLPHYT NGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAGLTESQSQSHKFKD EHQKIHRFRQGDVIALPAGVAHWCYNDCEVPVVAIYVTDINNGANQLDPR QRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQL QCQNDQKGEIVRVERGLSLLQPYASLQEQEQGQMQSREHYQEGGYQQSQY GSGCPNGLDETFCVNKVRQNIDNPNRADTYNPRAGRVTNLSQNFPILNLV QMSAVKVNLYQNTDTWISMGQEENALLSPFWNINAHSIVYITQGRAQVQV LRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRAL PTDVLANAYRISREEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [ SEQ ID NO: 530]

[0487] >gi|573943558| ref|XP_006654150.1| PREDICTED: glutelin type-A 3-like [Oryza brachyantha]

TABLE-US-00744 MKSSIVFSTICLVLLCHGSLAQLLSQSTSQWQSSRRGSPRQCRFDQLQAF EPIRTVRSQAGVTEFYDVSNELFQCTGVSVVRRVIEPRGLLLPHYSNGAT LVYIIQGRGITGPTFPGCPETYQQQFQQSGEAQPFEGQSHKFRDEHQKIH RFRQGDVVALPAGVAHWCYNDGEVPIVAIYVTDIYNSANQLDPRHRDFFL AGNNKVAQQLYRSEARENSKNIFGGFSVELLSEALGISRGVARQLQCQND QRGEIVRVEHGLALLQPYASVQEQQQEQVQSRDYEQTQYQQKQPQGSCSN GLDETFCTMRLRQNIDNPNLADTYNPKAGRITYLNGQKFPILNLVQMSAV KVNLYQNAVLSPFWNINAHSVVYITQGRARVQVVNNNGKTVFDGELRQGQ LLIIPQHHVVLKKAQREGCSYIALKTNPNSIVSHIAGKNSIFRALPGDVV TNAYRISREEAKRIKHNRGDESGVFAPSHAYRSYQDMSVAA [SEQ ID NO: 531]

[0488] >gi|721641733| ref|XP_010231907.1| PREDICTED: 12S seed storage globulin 1-like [Brachypodium distachyon]

TABLE-US-00745 MAHTSFSSFLSYFCLFLLFHGSMAQVLGQVSTWQSSRQGGSRDCSFDRLQ AIEPVTQVRSQAGLTEYFDEQNEQFRCAGVFVIRRVIEPRGLLLPRYHNT PGLVYILQGNGFVGLTFPGCPETFREQFQQFRQTQSTLGQSQCQSQKLGD VHQRVHQFTQGDVVALPTGVAHWIYNGGDAPVVIVYVFDVNNNANQLEPR QKEFLLGGNYNGVLQYGQNIFSGFNAQLLSQAFGINEQTSQRIQNQNDGR GDIIRVDNGLQFLKPVVTQQQPEQPFMPIQHQTGQSSRNGLEENFCSLEP RQNIEDPNRADTYNPRAGSITRLNGQNFPILNLVQMSATRVNLQKNAILS PFWNINAHSVVYVIQGHALVQVVNNQGHNVFNGLLHRGQLLIIPQNYVVL KKAESEGYQYIAFKTNANSMVSHIAGKNSILRALPVDVIANAYRISRQEA QNLKNNRGEETGVLTPNFSQSTCQSYQTEDVQSLRPMSHWSE [SEQ ID NO: 532]

Q0D7S0 (Rice)

[0489] >gi|169244463|gb|ACA50505.1| seed allergenic protein RAG2 [Oryza sativa Japonica Group]

TABLE-US-00746 MASNKVVFSALLLIIVSVLAATATMADHHKDQVVYSLGERCQPGMGYPMY SLPRCRAVVKRQCVGHGAPGGAVDEQLRQDCCRQLAAVDDSWCRCSALNH MVGGIYRELGATDVGHPMAXVFPGCRRGDLERAAASLPAFCNVDIPNGTG GVCYWLGYPRTPRTGH [SEQ ID NO:533]

[0490] >gi |5777592| emb | CAA44001.1 | low molecular weight globulin [Oryza sativa]

TABLE-US-00747 MASNKVVFSALLLIIVSVLRRDGTMADHHKDQVVYSLGERCQPGMGYPMY SLPRCRAVVKRQCVGHGAPGAVDEQLRQDCCRQLAAVDDSWCRCSALNHM VGGIYRELGATDVGHPMAEVFPGCRRGDLERAAASLPAFCNVDIPNGTGG VCYWLGYPRTPRTGH [SEQ ID NO: 534]

[0491] >gi 11154711751 ref|NP_001059186.1| Os07g0214600 [Oryza sativa Japonica Group] >gi 1236169541 dbj | BAC20657.1| allergen RA16 [Oryza sativa Japonica Group] >gi| 113610722 | dbj | BAF21100.1| Os07g0214600 [Oryza sativa Japonica Group] >gi | 125557687 |gb | EAZ03223.1| hypothetical protein Osl_25372 [Oryza sativa Indica Group]

TABLE-US-00748 MASNKVVISALLVVVVSVLAATTTMADHHQEQVVYTPGQLCQPGIGYPTY PLPRCRAFVKRQCVAPGTVDEQVRRGCCRQLAAIDSSWCRCDALNHMLRI IYRESGAADAGHPMAEVFRGCRRGDIERAAASLPAFCNVDIPNGVGGVCY WLPGTGY [SEQ ID NO: 535]

Q0DEV5 (Rice)

[0492] >gi |83375868| gb |ABC17777.1 | waxy [Oryza rufipogon]

TABLE-US-00749 MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSV TTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEMAPWSKTGG LGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERV RFFHCYKRGVDRVFVDHPSFLEKVWGKTGEKIYGPDTGVDYKDNQMRFSL LCQAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQPNGIY RNAKVAFCIHNISYQGRFAFEDYPELNLSERFRSSFDFIDGYDTPVEGRK INWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNG MDVSEWDPSKDKYITAKYDATTAIEAKALNKEALQAEAGLPVDRKIPLIA FIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSMEEKYP GKVRAVVKFNAPLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACA STGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKVVGTP AYEEMVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAPLAKE NVAAP [SEQ ID NO: 536]

[0493] >gi|297614332|gb|ADI48504.1| glycogen synthetase [Oryza officinalis]

TABLE-US-00750 MSALTTSQLATSATGFGIADRSAPSSLLRHCFQCLKPRSPACCDASSLSV TTSARATPKQQRSVQRCSRRFPSVVVYATCACMNVVFVCAEMAPWSKTGG LGDVLGGLPPAMAANGHRVMVISPRHDQYKDAWDTSVVAEIKVADRYERV RFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKIYGPDTGVDYKDNQMRFSL LCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLPSYLKNNYQP NGIYRNAKVAFCIHNISYQGRFAFEDYPELNLSERFRSSFDFIDGYDTPV EGRKINWMKAGILESDRVLTVSPYYAEELISGIARGCELDNIMRLTGITG IVNGMDVSEWDPSKDKYIAAKYDATTAIEAKALNKEALQAEAGLPVDRKI PLIAFIGRLEEQKGPDVMAAAIPELMQENVQIVLLGTGKKKFEKLLKSME EKYPGKVRAVVKFNAPLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTP CACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVQKVATTLKRAIKI VGTPAYNEMVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGVEGEEIAP LAKENVAAP [SEQ ID NO: 537]

[0494] >gi|389620054|gb|AFK93486.1| granule-bound starch synthase [Hordeum vulgare subsp. vulgare]

TABLE-US-00751 MAALATSQLATSGTVLGVTDRFRRPGFQGLRPRNPADAALGMRTIGASAA PKQSRKAHRGSRRCLSVVVRATGSGMNLVFVGAEMAPWSKTGGLGDVLGG LPPAMAANGHRVMVVSPRYDQYKDAWDTSVISEIKVADEYERVRFFHCYK RGVDRVFIDHPWFLEKVRGKTKEKIYGPDAGTDYEDNQQRFSLLCQAALE APRILNLNNNPYFSGPYGEDVVFVCNDWHTGLLACYLKSNYQSNGIYRTA KVAFCIHNISYQGRFSFDDFAQLNLPDRFKSSFDFIDGYDKPVEGRKINW MKAGILQADKVLTVSPYYAEELISDEARGCELDNIMRLTGITGIVNGMDV SEWDPTKDKFLAVNYDITTALEAKALNKEALQAEVGLPVDRKVPLVAFIG RLEEQKGPDVMIAAIPEILKEEDVQIILLGTGKKKFEKLLKSMEEKFPGK VRAVVRFNAPLAHQMMAGADLLAVTSRFEPCGLIQLQGMRYGTPCVCAST GGLVDTIVEGKTGFHMGRLSVDCNVVEPADVKKVATTLKRAVKVVGTPAY QEMVKNCMIQDLSWKGPAKNWEDVLLELGVEGSEPGIVGEEIAPLAMENV AAP [SEQ ID NO: 538]

P14323 (Rice)

[0495] >gi|573918992 | ref|XP_006647120.1| PREDICTED: glutelin type-B 2-like [Oryza brachyantha]

TABLE-US-00752 MATTVFSRFSTYFCVLLLCHGSMAQLFNPSTNPWHNPRQGSSRECRFDRL QPFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLLVPRYTN APGLVYIIQGRGSIGLTFPGCPATYQQQFQQFLPQEQSQSQKFRDEHQKI HQFRQGDIVALPAGVAHWFYNDGDAPVVAVYVYDVKNSANQLEPRQREFL LGGNNMRAQQVYGSSAEQHSRQNIFSGFGVEILSEALGISTVTTKRLQSQ NDQRGEIIHVKNGLQFLKPTLTQQQEQAQAQYQEVQYSEQQQTSSRWNGL DENFCTIKARMNIENTSRADTYNPRAGRTTSLNSQKFPILNLVQMSATRV NLYQNAILSTFWNVNAHSLVYTIQGRARVQVVSNFGKTVFDGELRPGQLL IIPQHYVVLKKAQREGFRYIAIKTNANAFVSQLVGKNSVFRSLPVDVIAN VYRISREQARSLKNNRGEEHGAFAPRSQQQSYPGFSNQSESETSE [SEQ ID NO: 539]

[0496] >gi | 573919041|ref|XP_006647142.1| PREDICTED: glutelin type-B 4-like [Oryza brachyantha]

TABLE-US-00753 MATTTFSRFSIYFCVLLLCHGSMAQLFSPTLNPWHSSRRGGSRDCRFDRL QAFEPLRRVRSEAGVTEYFDERNEQFQCTGTFVIRRVIEPQGLLVPRYTN TPGVVYIMQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKI HQFRQGDIVALPAGVAHWFYNEGDTPVVALYVFDINNSANQLEPRQKDFL LAGNNNREQQVYGRSIEKHSGQNIFSGFNHELLSEALGISTLAAKRLQGQ NDHRGEIIRVRNGLQLLKPTFTQQQEQAQSQYQVQYSEKQQESTRCNGLD ENFCTINARLNIENPSRADTYNPRAGRITHLNNQKFPILNLVQMSATRVN LYQNAILSPYWNVNAHSLVYMVQGHARVQVVSNLGKTVFNSVLRPGQLLI IPQHYVVLKKAEREGCQYIAFKTNANSIVSQLAGKNSILRAMPVDVVANA YRISREQARDLKNNRGEELGAFTPKFEQQSYPGLSNESESEASE [SEQ ID NO: 540]

[0497] >gi|109894635|gb|ABG47337.1| glutelin precursor [Zizania latifolia]

TABLE-US-00754 MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFD RLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRGLLLPQY TNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFK DEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVIDINNAANQLDP RQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQ LQCQNDQRGEIVRVEHGLSLLQPYASLQEQEQKQEQPRERYQVTQHQQSQ YGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILN LIQMSAVKVNLYQNALLSPFWNINSHSVVYVTQGCARVQVVNNNGKTVFN GELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFR ALPTDVLANAYRISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID NO: 541]

P29835 (Rice)

[0498] >gi |226508602| ref| NP_001152635.1| globulin precursor [Zea mays] >gi|195658363|gb|ACG48649.1| globulin precursor [Zea mays]

TABLE-US-00755 MAKIAAAAAAAAALCFAALVAVAVCQGEVERQRLRDLQCWQEVQESPLDA CRQVLDRQLTGGGVGGPFRWGTGLRMRCCQQLQDVSRECRCAAIRSMVRG YEEAMPPLEKGWWPWGRQQQPPPQGGGGGQGGYYYPCSRAGEGYQTQMYP PCRPGTTGPRIGRVRLTKAREYAAGLPMMCRLSEPQECSIFSGGDQY [S EQ ID NO: 542]

[0499] >gi|242090997| ref|XP_002441331.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghum bicolor] >gi|241946616|gb | EES19761.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghum bicolor]

TABLE-US-00756 MAKIAAVAATAALCLAALVAVAVGQGVVERQRLKDLQCWQEVQENPLGAC RQVLDRQLTGGMRYGIGPFRWGTGLRMRCCQQLQDVSRECRCAAIRSMVR GYEETMPPLEKGWWGQQPQPGYDYPCSQAGEGYGYGESGQQQMYPPCRPG TGQKIARVKLTKARQYAAGMPMMCRLSEPQECSVFSGGDQYY [SEQ ID NO: 543]

[0500] >gi | 514748428| ref |XP_004961615.1| PREDICTED: 19 kDa globulin-like [Setaria italica]

TABLE-US-00757 MAKFVVAAATAALCLAALVAMAAGQSGFERQRLRDLRCQREVEENPLWAC RQVLDRQLTGGMRYGVGPFRWGTGLRMRCCQQLQDVSRECRCSAVRRMVR GYEEAMPPLEEGPYGYGGEQGEGYYGGGEGGEGYLPFPPRRIGRVRLTKA RQYAAGLPMMCRLEPQECSVFSGDQYK[SEQ ID NO: 544]

P0C1U8 (Bacterial) GLUC (Staphylococcus Aureus)

[0501] >gi 14465991821 ref | WP_000676528.1 | glutamyl endopeptidase [Staphylococcus aureus] >gi | 253729369 | gb | EES98098.1 | trypsin [Staphylococcus aureus subsp. aureus TCH130] >gi|341844549|gb| EGS85761.1| glutamyl endopeptidase [Staphylococcus aureus subsp. aureus 21259] >gi|537390486|gb|AGU61109.1| Glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus CN1] >gi| 564714561 |gb| ETD14665.1| glutamyl endopeptidase [Staphylococcus aureus subsp. aureus KPL1845] >gi | 577466329|gb| EUG79766.1| glutamyl endopeptidase [Staphylococcus aureus M0139] >gi |580560623| gb | EVF84961.1| glutamyl endopeptidase [Staphylococcus aureus COAS6020] >gi |580687002| gb | EVH10169.1| glutamyl endopeptidase [Staphylococcus aureus UCIM6080] >gi |751815683| gb | KIN24957.1| glutamyl endopeptidase [Staphylococcus aureus MRSA_CVM43477] >gi|781884797|dbj|BAR08486.1| glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus] >gi |781887762| dbj | BAR11210.1| glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus]

TABLE-US-00758 MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQSQSSKQQTP KIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYIQVEAPTG TFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTA EQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMSNNAETQVNQNITVT GYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIG IHWGGVPNEFNGAVFINENVRNFLKQNIEDIHFANDDQPNNPDNPDNPNN PDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID NO: 5 45]

GROWTH PROMOTING PEPTIDES, AND USES THEREOF

Assignee

Inventors

Cpc classification

Classification Explorer

Y02P20/55

GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Classification Explorer

A61Q19/08

HUMAN NECESSITIES

Classification Explorer

A61K38/01

HUMAN NECESSITIES

Classification Explorer

A61P17/02

HUMAN NECESSITIES

Classification Explorer

C12Y113/11012

CHEMISTRY; METALLURGY

Classification Explorer

C12N9/0069

CHEMISTRY; METALLURGY

Classification Explorer

C07K14/415

CHEMISTRY; METALLURGY

Classification Explorer

A61F13/00063

HUMAN NECESSITIES

Classification Explorer

A61F2013/00361

HUMAN NECESSITIES

Classification Explorer

A61K8/64

HUMAN NECESSITIES

Classification Explorer

A61K9/0014

HUMAN NECESSITIES

Classification Explorer

A61K38/011

HUMAN NECESSITIES

Classification Explorer

A61F2013/00089

HUMAN NECESSITIES

Classification Explorer

A61P35/00

HUMAN NECESSITIES

Classification Explorer

A61K38/00

HUMAN NECESSITIES

International classification

Classification Explorer

A61K38/01

HUMAN NECESSITIES

Classification Explorer

C07K14/415

CHEMISTRY; METALLURGY

Classification Explorer

A61Q19/08

HUMAN NECESSITIES

Classification Explorer

A61K8/64

HUMAN NECESSITIES

Classification Explorer

C12N9/02

CHEMISTRY; METALLURGY

Classification Explorer

A61P17/02

HUMAN NECESSITIES

Classification Explorer

A61P35/00

HUMAN NECESSITIES

Classification Explorer

A61F13/00

HUMAN NECESSITIES

Classification Explorer

A61K9/00

HUMAN NECESSITIES

Abstract

Claims

Description